Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Dec. 31, 2017 | Jan. 31, 2018 | |
Document and Entity Information [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Dec. 31, 2017 | |
Document Fiscal Year Focus | 2,018 | |
Document Fiscal Period Focus | Q1 | |
Trading Symbol | NUAN | |
Entity Registrant Name | Nuance Communications, Inc. | |
Entity Central Index Key | 1,002,517 | |
Current Fiscal Year End Date | --09-30 | |
Entity Filer Category | Large Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 293,699,330 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Document Period End Date | Dec. 31, 2017 | |
Revenues: | ||
Professional services and hosting | $ 259,027 | $ 253,417 |
Product and licensing | 161,810 | 151,752 |
Maintenance and support | 80,808 | 82,489 |
Total revenues | 501,645 | 487,658 |
Cost of revenues: | ||
Professional services and hosting | 172,528 | 164,892 |
Product and licensing | 19,069 | 18,378 |
Maintenance and support | 14,241 | 13,598 |
Amortization of intangible assets | 15,356 | 15,542 |
Total cost of revenues | 221,194 | 212,410 |
Gross profit | 280,451 | 275,248 |
Operating expenses: | ||
Research and development | 73,366 | 66,322 |
Sales and marketing | 101,960 | 101,516 |
General and administrative | 52,892 | 39,790 |
Amortization of intangible assets | 23,064 | 27,859 |
Acquisition-related costs, net | 5,561 | 9,026 |
Restructuring and other charges, net | 14,801 | 6,703 |
Total operating expenses | 271,644 | 251,216 |
Income from operations | 8,807 | 24,032 |
Other (expense) income: | ||
Interest income | 2,192 | 1,023 |
Interest expense | (36,070) | (38,021) |
Other expense, net | (222) | (610) |
Loss before income taxes | (25,293) | (13,576) |
(Benefit) provision for income taxes | (78,521) | 10,353 |
Net income (loss) | $ 53,228 | $ (23,929) |
Net income (loss) per share: | ||
Basic (in dollars per share) | $ 0.18 | $ (0.08) |
Diluted (in dollars per share) | $ 0.18 | $ (0.08) |
Weighted average common shares outstanding: | ||
Basic (in shares) | 291,367 | 288,953 |
Diluted (in shares) | 295,995 | 288,953 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Net income (loss) | $ 53,228 | $ (23,929) |
Other comprehensive income (loss): | ||
Foreign currency translation adjustment | 1,515 | (30,566) |
Pension Adjustments | 116 | 118 |
Unrealized (loss) gain on marketable securities | (277) | (31) |
Total other comprehensive income (loss), net | 1,354 | (30,479) |
Comprehensive income (loss) | $ 54,582 | $ (54,408) |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2017 | Sep. 30, 2017 |
Current assets: | ||
Cash and cash equivalents | $ 398,461 | $ 592,299 |
Marketable securities | 112,044 | 251,981 |
Accounts receivable, less allowances for doubtful accounts of $13,013 and $14,333 | 432,552 | 395,392 |
Prepaid expenses and other current assets | 105,411 | 88,269 |
Total current assets | 1,048,468 | 1,327,941 |
Marketable Securities, Noncurrent | 42,115 | 29,844 |
Land, building and equipment, net | 172,748 | 176,548 |
Goodwill | 3,600,768 | 3,590,608 |
Intangible assets, net | 627,556 | 664,474 |
Other assets | 145,902 | 142,508 |
Total assets | 5,637,557 | 5,931,923 |
Current liabilities: | ||
Current portion of long-term debt | 0 | 376,121 |
Contingent And Deferred Acquisition Payments | 15,506 | 28,860 |
Accounts payable | 82,674 | 94,604 |
Accrued expenses and other current liabilities | 193,406 | 245,901 |
Deferred revenue | 427,541 | 366,042 |
Total current liabilities | 719,127 | 1,111,528 |
Long-term debt | 2,299,594 | 2,241,283 |
Deferred revenue, net of current portion | 453,106 | 423,929 |
Deferred tax liabilities | 35,769 | 131,320 |
Other liabilities | 104,830 | 92,481 |
Total liabilities | 3,612,426 | 4,000,541 |
Commitments and contingencies | ||
Stockholders’ equity: | ||
Common stock, $0.001 par value per share; 560,000 shares authorized; 297,243 and 293,938 shares issued and 293,492 and 290,187 shares outstanding, respectively | 297 | 294 |
Additional paid-in capital | 2,669,291 | 2,629,245 |
Treasury stock, at cost (3,751 shares) | (16,788) | (16,788) |
Accumulated other comprehensive loss | (99,988) | (101,342) |
Accumulated deficit | (527,681) | (580,027) |
Total stockholders’ equity | 2,025,131 | 1,931,382 |
Total liabilities and stockholders’ equity | $ 5,637,557 | $ 5,931,923 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) shares in Thousands, $ in Thousands | Dec. 31, 2017 | Sep. 30, 2017 |
Accounts receivable, allowances for doubtful accounts | $ 13,013 | $ 14,333 |
Common stock, par value | $ 0.001 | $ 0.001 |
Common stock, shares authorized | 560,000 | 560,000 |
Common stock, shares issued | 297,243 | 293,938 |
Common stock, shares outstanding | 293,492 | 290,187 |
Treasury stock, shares | 3,751 | 3,751 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Cash flows from operating activities: | ||
Net income (loss) | $ 53,228 | $ (23,929) |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
Depreciation and amortization | 54,315 | 58,006 |
Stock-based compensation | 37,986 | 39,130 |
Non-cash interest expense | 13,341 | 13,039 |
Deferred tax (benefit) provision | (97,226) | 2,006 |
Other | 631 | 1,856 |
Changes in operating assets and liabilities, excluding effects of acquisitions: | ||
Accounts receivable | (36,340) | (9,713) |
Prepaid expenses and other assets | (18,972) | (15,999) |
Accounts payable | (11,856) | (21,244) |
Accrued expenses and other liabilities | 3,099 | 5,841 |
Deferred revenue | 87,899 | 75,907 |
Net cash provided by operating activities | 86,105 | 124,900 |
Cash flows from investing activities: | ||
Capital expenditures | (12,543) | (11,399) |
Payments for business and asset acquisitions, net of cash acquired | (8,648) | (22,949) |
Purchase of marketable securities and other investments | (32,447) | (72,797) |
Proceeds from sales and maturities of marketable securities and other investments | 159,805 | 10,105 |
Net cash provided by (used in) investing activities | 106,167 | (97,040) |
Cash flows from financing activities: | ||
Payments and redemption of debt | (331,172) | 0 |
Proceeds from Issuance of Long-term Debt | 0 | 495,000 |
Payment for Contingent Consideration Liability, Financing Activities | (16,880) | 0 |
Payments of other long-term liabilities | (65) | (87) |
Proceeds from issuance of common stock from employee stock plans | 6 | 45 |
Cash used to net share settle employee equity awards | (38,617) | (40,360) |
Net cash (used in) provided by financing activities | (386,728) | 454,598 |
Effects of exchange rate changes on cash and cash equivalents | 618 | (2,471) |
Net (decrease) increase in cash and cash equivalents | (193,838) | 479,987 |
Cash and cash equivalents at beginning of period | 592,299 | 481,620 |
Cash and cash equivalents at end of period | $ 398,461 | $ 961,607 |
Organization and Presentation
Organization and Presentation | 3 Months Ended |
Dec. 31, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Presentation | Organization and Presentation The condensed consolidated financial statements include the accounts of Nuance Communications, Inc. (“Nuance”, “we”, "our", or “the Company”) and our wholly-owned subsidiaries. We prepared the unaudited interim condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (the “U.S.” or the "United States") and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). The condensed consolidated financial statements reflect all normal and recurring adjustments that, in our opinion, are necessary to present fairly our financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts and classifications of assets and liabilities, disclosure of contingent assets and liabilities, and the reported amounts of revenues and expenses during the reporting period. Although we believe the disclosures included herein are adequate to ensure that the condensed consolidated financial statements are fairly presented, certain information and footnote disclosures to the financial statements have been condensed or omitted in accordance with the rules and regulations of the SEC. Accordingly, the condensed consolidated financial statements and the footnotes included herein should be read in conjunction with the audited financial statements and the footnotes included in our Annual Report on Form 10-K for the fiscal year ended September 30, 2017 . The results of operations for the three months ended December 31, 2017 and 2016 , are not necessarily indicative of the results for the entire fiscal year or any future period. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended |
Dec. 31, 2017 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Summary of Significant Accounting Policies Recently Adopted Accounting Standards In October 2016, the FASB issued ASU 2016-16, "Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory" ("ASU 2016-16"), which requires income tax consequences of inter-company transfers of assets other than inventory to be recognized when the transfer occurs. ASU 2016-16 is effective for fiscal years beginning after December 15, 2017, with early adoption permitted. We early adopted the guidance during the first quarter of fiscal year 2018. As a result, deferred tax liabilities of $0.9 million arising from inter-company transfers in prior years were recognized and recorded against the beginning balance of accumulated deficit in the first quarter of fiscal year 2018. The adoption of the guidance does not have a material impact on our consolidated financial statements for any period presented. Recently Issued Accounting Standards In August 2016, the FASB issued ASU 2016-15, "Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments" ("ASU 2016-15"), which is effective for fiscal years beginning after December 15, 2017 and the interim periods therein, with early adoption permitted. The guidance requires cash flows with multiple characteristics to be classified using a three-step process, including (i) determining whether explicit guidance is applicable, (ii) separating each identifiable source or use of cash flows, and (iii) determining the predominant source or use of cash flows when the source or use of cash flows cannot be separately identifiable. We are still evaluating the impact of the guidance on our consolidated financial statement. In February 2016, the FASB issued ASU No. 2016-02, "Leases" ("ASU 2016-02"). ASU 2016-02 requires lessees to recognize on the balance sheet a right-of-use asset, representing its right to use the underlying asset for the lease term, and a lease liability for all leases with terms greater than 12 months. The guidance also requires qualitative and quantitative disclosures designed to assess the amount, timing, and uncertainty of cash flows arising from leases. The standard requires the use of a modified retrospective transition approach, which includes a number of optional practical expedients that entities may elect to apply. ASU 2016-02 is effective for us in the first quarter of fiscal year 2020, and early application is permitted. We are currently evaluating the impact of our pending adoption of ASU 2016-02 on our consolidated financial statements, and we currently expect that most of our operating lease commitments will be subject to the new standard and recognized as operating lease liabilities and right-of-use assets upon our adoption of ASU 2016-02, which will increase our total assets and total liabilities that we report relative to such amounts prior to adoption. In January 2016, the FASB issued ASU No. 2016-01, "Recognition and Measurement of Financial Assets and Financial Liabilities" ("ASU 2016-01"). ASU 2016-01 amends the guidance on the classification and measurement of financial instruments. Although ASU 2016-01 retains many current requirements, it significantly revises accounting related to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for financial liabilities measured at fair value. ASU 2016-01 also amends certain disclosure requirements associated with the fair value of financial instruments and is effective for us in the first quarter of fiscal year 2019. Based on the composition of our investment portfolio, we do not believe the adoption of ASU 2016-01 will have a material impact on our consolidated financial statements. In May 2014, the FASB issued ASU No. 2014-09, "Revenue from Contracts with Customers: Topic 606" ("ASU 2014-09"), to supersede nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing U.S. GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 permits two methods of adoption: (i) retrospective to each prior reporting period presented; or (ii) retrospective with the cumulative effect of initially applying the guidance recognized at the date of initial application. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, which deferred the effective date of the new revenue standard for periods beginning after December 15, 2016 to December 15, 2017, with early adoption permitted but not earlier than the original effective date. Accordingly, the updated standard is effective for us in the first quarter of fiscal 2019 and we do not plan to early adopt. In the first quarter of fiscal 2017, we commenced a project to assess the potential impact of the new standard on our consolidated financial statements and related disclosures. This project also includes the assessment and enhancement of our internal processes and systems to address the new standard. While we are continuing to assess all potential impacts of the new standard, we currently believe the most significant impact relates to our accounting for arrangements that include term-based software licenses bundled with maintenance and support. Under current GAAP, the revenue attributable to these software licenses is recognized ratably over the term of the arrangement because vendor-specific objective evidence ("VSOE") does not exist for the undelivered maintenance and support element as it is not sold separately. The requirement to have VSOE for undelivered elements to enable the separation of revenue for the delivered software licenses is eliminated under the new standard. Accordingly, under the new standard we will be required to recognize as revenue a portion of the arrangement fee upon delivery of the software license. While we currently expect revenue related to our professional services and cloud offerings to remain substantially unchanged, we are still in the process of evaluating the impact of the new standard on these arrangements. We plan to adopt this guidance beginning on October 1, 2018 and apply the cumulative catch-up transition method, with a cumulative adjustment to retained earnings as opposed to retrospectively adjusting prior periods. |
Business Acquisitions
Business Acquisitions | 3 Months Ended |
Dec. 31, 2017 | |
Business Combinations [Abstract] | |
Business Acquisitions | Business Acquisitions We continue to expand our solutions and integrate our technologies in new offerings through acquisitions. A summary of our acquisition activities for the three months ended December 31, 2017 and December 31, 2016 is as follows: Fiscal Year 2018 In the first quarter of fiscal year 2018, we completed an acquisition in our Healthcare segment for a total cash consideration of $8.7 million and contingent payments at fair value of $0.5 million . As a result, we recognized goodwill of $6.8 million , and other intangible assets of $2.0 million , with a weighted average life of 2.0 years . The acquisition does not have a material impact on our condensed consolidated financial statements for the period. Fiscal Year 2017 In the first quarter of fiscal year 2017, we completed several acquisitions in our Enterprise and Healthcare segments for a total cash consideration of $24.2 million and contingent payments at fair value of $1.7 million . As a result, we recognized goodwill of $15.7 million , and other intangible assets of $10.4 million , with a weighted average life of 6.0 years . Such acquisitions were not significant individually or in the aggregate. Acquisition-Related Costs, net Acquisition-related costs include costs related to business acquisitions. These costs consist of (i) transition and integration costs, including retention payments, transitional employee costs and earn-out payments, and other costs related to integration activities; (ii) professional service fees, including financial advisory, legal, accounting, and other outside services incurred in connection with acquisition activities, and disputes and regulatory matters related to acquired entities; and (iii) fair value adjustments to acquisition-related contingencies. A summary of acquisition-related costs, net is as follows (dollars in thousands): Three Months Ended December 31, 2017 2016 Transition and integration costs $ 4,062 $ 3,710 Professional service fees 511 5,017 Acquisition-related adjustments 988 299 Total $ 5,561 $ 9,026 |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 3 Months Ended |
Dec. 31, 2017 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets | Goodwill and Intangible Assets The changes in the carrying amount of goodwill and intangible assets for the three months ended December 31, 2017 are as follows (dollars in thousands): Goodwill Intangible Assets Balance at September 30, 2017 $ 3,590,608 $ 664,474 Acquisitions (Note 3) 6,790 2,000 Purchase accounting adjustments (348 ) — Amortization — (38,420 ) Effect of foreign currency translation 3,718 (498 ) Balance at December 31, 2017 $ 3,600,768 $ 627,556 |
Financial Instruments and Hedgi
Financial Instruments and Hedging Activities | 3 Months Ended |
Dec. 31, 2017 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Financial Instruments and Hedging Activities | Financial Instruments and Hedging Activities Derivatives Not Designated as Hedges Forward Currency Contracts We utilize foreign currency forward contracts to mitigate the risks associated with changes in foreign currency exchange rates. Generally, we enter into such contracts for less than 90 days and have no cash requirements until maturity. At December 31, 2017 and September 30, 2017 , we had outstanding contracts with a total notional value of $82.4 million and $69.0 million , respectively. We did not designate any forward contracts as hedging instruments for the three months ended December 31, 2017 or 2016. Therefore, changes in fair value of foreign currency forward contracts were recognized within other expense, net in our condensed consolidated statements of operations. The cash flows related to the settlement of forward contracts not designated as hedging instruments are included in cash flows from investing activities within our consolidated statement of cash flows. A summary of the derivative instruments as of December 31, 2017 and September 30, 2017 is as follows (dollars in thousands): Derivatives Not Designated as Hedges: Balance Sheet Classification Fair Value December 31, September 30, Foreign currency forward contracts Prepaid expenses and other current assets $ 535 $ 220 Foreign currency forward contracts Accrued expenses and other current liabilities (65 ) (373 ) A summary of loss related to the derivative instruments for the three months ended December 31, 2017 and 2016 is as follows (dollars in thousands): Three Months Ended December 31, Derivatives Not Designated as Hedges Classification of Loss Recognized in Income 2017 2016 Foreign currency forward contracts Other expense, net $ (397 ) $ (11,615 ) |
Fair Value Measures
Fair Value Measures | 3 Months Ended |
Dec. 31, 2017 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measures | Fair Value Measurements Fair value is defined as the price that would be received to sell an asset, or paid to transfer a liability, in an orderly transaction between market participants at the measurement date. Valuation techniques must maximize the use of observable inputs and minimize the use of unobservable inputs. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and consider assumptions that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk of nonperformance. The determination of the applicable level within the hierarchy of a particular financial asset or liability depends on the lowest level of inputs that are significant to the fair value measurement as of the measurement date as follows: • Level 1: Quoted prices for identical assets or liabilities in active markets. • Level 2: Observable inputs other than those described as Level 1. • Level 3: Unobservable inputs that are supportable by little or no market activities and are based on significant assumptions and estimates. Assets and liabilities measured at fair value on a recurring basis at December 31, 2017 and September 30, 2017 consisted of the following (dollars in thousands): December 31, 2017 Level 1 Level 2 Level 3 Total Assets: Money market funds (a) $ 245,036 $ — $ — $ 245,036 Time deposits (b) — 99,774 — 99,774 Commercial paper, $38,069 at cost (b) — 38,182 — 38,182 Corporate notes and bonds, $83,827 at cost (b) — 83,532 — 83,532 Foreign currency exchange contracts (b) — 535 — 535 Total assets at fair value $ 245,036 $ 222,023 $ — $ 467,059 Liabilities: Foreign currency exchange contracts (b) $ — $ (65 ) $ — $ (65 ) Contingent acquisition payments (c) — — (10,431 ) (10,431 ) Total liabilities at fair value $ — $ (65 ) $ (10,431 ) $ (10,496 ) September 30, 2017 Level 1 Level 2 Level 3 Total Assets: Money market funds (a) $ 381,899 $ — $ — $ 381,899 Time deposits (b) — 85,570 — 85,570 Commercial paper, $41,805 at cost (b) — 41,968 — 41,968 Corporate notes and bonds, $74,150 at cost (b) — 74,067 — 74,067 Foreign currency exchange contracts (b) — 220 — 220 Total assets at fair value $ 381,899 $ 201,825 $ — $ 583,724 Liabilities: Foreign currency exchange contracts (b) $ — $ (373 ) $ — $ (373 ) Contingent acquisition payments (c) — — (8,648 ) (8,648 ) Total liabilities at fair value $ — $ (373 ) $ (8,648 ) $ (9,021 ) (a) Money market funds and time deposits with original maturity of 90 days or less are included within cash and cash equivalents in the consolidated balance sheets, are valued at quoted market prices in active markets. (b) Time deposits, commercial paper, corporate notes and bonds, and foreign currency exchange contracts are recorded at fair market values, which are determined based on the most recent observable inputs for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active or are directly or indirectly observable. Time deposits are generally for terms of one year or less. Commercial paper and corporate notes and bonds generally mature within three years and have a weighted average maturity of 0.54 years as of December 31, 2017 and 0.72 years as of September 30, 2017 . (c) The fair values of our contingent consideration arrangements were determined using either the option pricing model with Monte Carlo simulation or probability-weighted discounted cash flow method. As of September 30, 2017, $80.2 million of debt securities included within marketable securities were designated as held-to-maturity investments, which had a weighted average maturity of 0.27 years and an estimated fair value of $80.4 million based on Level 2 measurements. No debt securities were designated as held-to-maturity investments as of December 31, 2017. The estimated fair value of our long-term debt approximated $2,627.2 million (face value $2,587.0 million ) and $2,930.9 million (face value $2,918.1 million ) as of December 31, 2017 and September 30, 2017 , respectively, based on Level 2 measurements. The fair value of each borrowing was estimated using the averages of the bid and ask trading quotes at each respective reporting date. There was no balance outstanding under our revolving credit agreement as of December 31, 2017 or September 30, 2017 . Additionally, contingent acquisition payments are recorded at fair values upon the acquisition, and remeasured in subsequent reporting periods with the changes in fair values recorded within acquisition-related costs, net. Such payments are contingent upon the achievement of specified performance targets and are valued using the option pricing model with Monte Carlo simulation or the probability-weighted discounted cash flow model. The following table provides a summary of changes in the aggregate fair value of the contingent acquisition payments for the three months ended December 31, 2017 and 2016 (dollars in thousands): Three Months Ended December 31, 2017 2016 Balance at beginning of period $ 8,648 $ 8,240 Earn-out liabilities established at time of acquisition 500 1,653 Payments and foreign currency translation (17 ) (1,498 ) Adjustments to fair value included in acquisition-related costs, net 1,300 566 Balance at end of period $ 10,431 $ 8,961 Contingent acquisition payments are to be made in periods through fiscal year 2019 . As of December 31, 2017 , the maximum amount payable based on the agreements was $25.1 million if the specified performance targets are achieved. |
Accrued Expenses and Other Curr
Accrued Expenses and Other Current Liabilities | 3 Months Ended |
Dec. 31, 2017 | |
Payables and Accruals [Abstract] | |
Accrued Expenses and Other Current Liabilities | Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (dollars in thousands): December 31, September 30, Compensation $ 103,991 $ 159,951 Cost of revenue related liabilities 22,066 20,124 Accrued interest payable 21,733 26,285 Consulting and professional fees 19,274 12,649 Facilities related liabilities 5,540 7,158 Sales and marketing incentives 4,190 3,655 Sales and other taxes payable 3,190 3,125 Other 13,422 12,954 Total $ 193,406 $ 245,901 |
Deferred Revenue
Deferred Revenue | 3 Months Ended |
Dec. 31, 2017 | |
Deferred Revenue [Abstract] | |
Deferred Revenue | Deferred Revenue Deferred maintenance revenue consists of prepaid fees received for post-contract customer support for our products, including telephone support and the right to receive unspecified upgrades/updates on a when-and-if-available basis. Unearned revenue includes fees for up-front setup of the service environment; fees charged for on-demand service; certain software arrangements for which we do not have fair value of post-contract customer support, resulting in ratable revenue recognition for the entire arrangement on a straight-line basis; and fees in excess of estimated earnings on percentage-of-completion service contracts. Deferred revenue consisted of the following (dollars in thousands): December 31, September 30, Current liabilities: Deferred maintenance revenue $ 171,980 $ 162,958 Unearned revenue 255,561 203,084 Total current deferred revenue $ 427,541 $ 366,042 Long-term liabilities: Deferred maintenance revenue $ 62,494 $ 60,298 Unearned revenue 390,612 363,631 Total long-term deferred revenue $ 453,106 $ 423,929 |
Restructuring and Other Charges
Restructuring and Other Charges, net | 3 Months Ended |
Dec. 31, 2017 | |
Restructuring and Related Activities [Abstract] | |
Restructuring and Related Activities Disclosure [Text Block] | Restructuring and Other Charges, net Restructuring and other charges, net include restructuring expenses together with other charges that are unusual in nature, are the result of unplanned events, or arise outside of the ordinary course of our business. The following table sets forth accrual activity relating to restructuring reserves for the three months ended December 31, 2017 (dollars in thousands): Personnel Facilities Total Balance at September 30, 2017 $ 1,546 $ 9,159 $ 10,705 Restructuring charges, net 4,883 1,665 6,548 Non-cash adjustment — (298 ) (298 ) Cash payments (5,392 ) (1,753 ) (7,145 ) Balance at December 31, 2017 $ 1,037 $ 8,773 $ 9,810 While restructuring and other charges, net are excluded from our calculation of segment profit, the table below presents the restructuring and other charges, net associated with each segment (dollars in thousands): Three Months Ended December 31, 2017 2016 Personnel Facilities Total Restructuring Other Charges Total Personnel Facilities Total Restructuring Other Charges Total Healthcare $ 2,513 $ 25 $ 2,538 $ — $ 2,538 $ 1,984 $ 277 $ 2,261 $ — $ 2,261 Mobile 400 11 411 — 411 213 — 213 — 213 Enterprise 262 2,360 2,622 — 2,622 424 607 1,031 — 1,031 Imaging 1,223 9 1,232 — 1,232 361 351 712 — 712 Corporate 485 (740 ) (255 ) 8,253 7,998 669 664 1,333 1,153 2,486 Total $ 4,883 $ 1,665 $ 6,548 $ 8,253 $ 14,801 $ 3,651 $ 1,899 $ 5,550 $ 1,153 $ 6,703 Fiscal Year 2018 During the three months ended December 31, 2017 , we recorded restructuring charges of $6.5 million , which included $4.9 million related to the termination of approximately 160 employees and $1.7 million related to certain excess facilities. These actions were part of our initiatives to reduce costs and optimize processes. We expect the remaining outstanding severance of $1.0 million to be substantially paid during fiscal year 2018 , and the remaining balance of $8.8 million related to excess facilities to be paid through fiscal year 2025 , in accordance with the terms of the applicable leases. Additionally, during the three months ended December 31, 2017 , we recorded $2.3 million related to the transition agreement of our CEO, and $6.0 million related to our remediation and restoration efforts after the malware incident that occurred in the third quarter of fiscal year 2017. The cash payments associated with the transition agreement are expected to be made during fiscal years 2018 and 2019. Fiscal Year 2017 During the three months ended December 31, 2016 , we recorded restructuring charges of $5.6 million . The restructuring charges for the three months ended December 31, 2016 included $3.7 million related to the termination of approximately 90 employees and $1.9 million related to certain excess facilities. These actions were part of our initiatives to reduce costs and optimize processes. The restructuring charges also included $1.9 million related to excess facilities. In addition, during the three months ended December 31, 2016 , we recorded $1.2 million related to the transition agreement of our CEO. |
Debt and Credit Facilities
Debt and Credit Facilities | 3 Months Ended |
Dec. 31, 2017 | |
Debt Disclosure [Abstract] | |
Debt and Credit Facilities | Debt At December 31, 2017 and September 30, 2017 , we had the following long-term borrowing obligations (dollars in thousands): December 31, September 30, 5.625% Senior Notes due 2026, net of deferred issuance costs of $5.5 million and $5.7 million, respectively. Effective interest rate 5.625%. $ 494,453 $ 494,298 5.375% Senior Notes due 2020, net of unamortized premium of $0.9 million and $1.0 million, respectively, and deferred issuance costs of $2.1 million and $2.3 million, respectively. Effective interest rate 5.375%. 448,748 448,630 6.000% Senior Notes due 2024, net of deferred issuance costs of $2.0 million and $2.1 million, respectively. Effective interest rate 6.000%. 297,988 297,910 1.00% Convertible Debentures due 2035, net of unamortized discount of $135.0 million and $140.9 million, respectively, and deferred issuance costs of $6.6 million and $6.9 million, respectively. Effective interest rate 5.622%. 534,885 528,690 2.75% Convertible Debentures due 2031, net of unamortized discount of $1.5 million and deferred issuance costs of $0.1 million as of September 30, 2017. Effective interest rate 7.432%. 46,568 376,121 1.25% Convertible Debentures due 2025, net of unamortized discount of $90.2 million and $92.7 million, respectively, and deferred issuance costs of $4.1 million and $4.3 million, respectively. Effective interest rate 5.578%. 255,703 253,054 1.50% Convertible Debentures due 2035, net of unamortized discount of $40.1 million and $42.5 million, respectively, and deferred issuance costs of $1.4 million and $1.5 million, respectively. Effective interest rate 5.394%. 222,340 219,875 Deferred issuance costs related to our Revolving Credit Facility (1,091 ) (1,174 ) Total debt 2,299,594 2,617,404 Less: current portion — 376,121 Total long-term debt $ 2,299,594 $ 2,241,283 The following table summarizes the maturities of our borrowing obligations as of December 31, 2017 (dollars in thousands): Fiscal Year Convertible Debentures (1) Senior Notes Total 2018 $ — $ — $ — 2019 — — — 2020 — 450,000 450,000 2021 — — — 2022 310,463 — 310,463 Thereafter 1,026,488 800,000 1,826,488 Total before unamortized discount 1,336,951 1,250,000 2,586,951 Less: unamortized discount and issuance costs (277,455 ) (9,902 ) (287,357 ) Total long-term debt $ 1,059,496 $ 1,240,098 $ 2,299,594 (1) Pursuant to the terms of each convertible instrument, holders have the right to redeem the debt on specific dates prior to maturity. The repayment schedule above assumes that payment is due on the next redemption date after December 31, 2017 . 5.625% Senior Notes due 2026 In December 2016 , we issued $500.0 million aggregate principal amount of 5.625% Senior Notes due on December 15, 2026 (the "2026 Senior Notes") in a private placement. The proceeds from the 2026 Senior Notes were approximately $495.0 million , net of issuance costs, and we used the proceeds to repurchase a portion of our 2020 Senior Notes. The 2026 Senior Notes bear interest at 5.625% per year, payable in cash semi-annually in arrears, beginning on June 15, 2017. The 2026 Senior Notes are unsecured senior obligations and are guaranteed on an unsecured senior basis by certain of our domestic subsidiaries ("Subsidiary Guarantors"). The 2026 Senior Notes and the guarantees rank equally in right of payment with all of our and the Subsidiary Guarantors’ existing and future unsecured senior debt and rank senior in right of payment to all of our and the Subsidiary Guarantors’ future unsecured subordinated debt. The 2026 Senior Notes and guarantees effectively rank junior to all our secured debt and that of the Subsidiary Guarantors to the extent of the value of the collateral securing such debt and to all liabilities, including trade payables, of our subsidiaries that have not guaranteed the 2026 Senior Notes. At any time before December 15, 2021 , we may redeem all or a portion of the 2026 Senior Notes at a redemption price equal to 100% of the aggregate principal amount of the 2026 Senior Notes to be redeemed, plus a “make-whole” premium and accrued and unpaid interest to, but excluding, the redemption date. At any time on or after December 15, 2021 , we may redeem all or a portion of the 2026 Senior Notes at certain redemption prices expressed as percentages of the principal amount, plus accrued and unpaid interest to, but excluding, the redemption date. At any time and from time to time before December 15, 2021 , we may redeem up to 35% of the aggregate outstanding principal amount of the 2026 Senior Notes with the net cash proceeds received by us from certain equity offerings at a price equal to 105.625% of the aggregate principal amount, plus accrued and unpaid interest to, but excluding, the redemption date, provided that the redemption occurs no later than 120 days after the closing of the related equity offering, and at least 50% of the original aggregate principal amount of the 2026 Senior Notes remains outstanding immediately thereafter. Upon the occurrence of certain asset sales or a change in control, we must offer to repurchase the 2026 Senior Notes at a price equal to 100% in the case of an asset sale, or 101% in the case of a change of control, of the principal amount plus accrued and unpaid interest to, but excluding, the repurchase date. 5.375% Senior Notes due 2020 In August 2012, we issued $700.0 million aggregate principal amount of 5.375% Senior Notes due on August 15, 2020 in a private placement. In October 2012, we issued an additional $350.0 million aggregate principal amount of our 5.375% Senior Notes (collectively the “2020 Senior Notes”). The 2020 Senior Notes bear interest at 5.375% per year, payable in cash semi-annually in arrears. The 2020 Senior Notes are our unsecured senior obligations and are guaranteed on an unsecured senior basis by certain of our domestic subsidiaries, ("the Subsidiary Guarantors"). The 2020 Senior Notes and guarantees rank equally in right of payment with all of our and the Subsidiary Guarantors' existing and future unsecured senior debt and rank senior in right of payment to all of our and the Subsidiary Guarantors' future unsecured subordinated debt. The 2020 Senior Notes and guarantees effectively rank junior to all secured debt of our and the Subsidiary Guarantors to the extent of the value of the collateral securing such debt and to all liabilities, including trade payables, of our subsidiaries that have not guaranteed the 2020 Senior Notes. In January 2017, we repurchased $600.0 million in aggregate principal amount of our 2020 Senior Notes using cash and cash equivalents and the net proceeds from our 2026 Senior Notes issued in December 2016. In January 2017, we recorded an extinguishment loss of $18.6 million . In accordance with the authoritative guidance for debt instruments, a loss on extinguishment is equal to the difference between the reacquisition price and the net carrying amount of the extinguished debt, including any unamortized debt discount or issuance costs. Following this activity, $450.0 million in aggregate principal amount of our 2020 Senior Notes remains outstanding. 6.0% Senior Notes due 2024 In June 2016 , we issued $300.0 million aggregate principal amount of 6.0% Senior Notes due on July 1, 2024 (the "2024 Senior Notes") in a private placement. The proceeds from the 2024 Senior Notes were approximately $297.5 million , net of issuance costs. The 2024 Senior Notes bear interest at 6.0% per year, payable in cash semi-annually in arrears. The 2024 Senior Notes are unsecured senior obligations and are guaranteed on an unsecured senior basis by our Subsidiary Guarantors. The 2024 Senior Notes and the guarantees rank equally in right of payment with all of our and the Subsidiary Guarantors’ existing and future unsecured senior debt, and rank senior in right of payment to all of our and the Subsidiary Guarantors’ future unsecured subordinated debt. The 2024 Senior Notes and guarantees effectively rank junior to all our secured debt and that of the Subsidiary Guarantors to the extent of the value of the collateral securing such debt and to all liabilities, including trade payables, of our subsidiaries that have not guaranteed the 2024 Senior Notes. 1.0% Convertible Debentures due 2035 In December 2015, we issued $676.5 million in aggregate principal amount of 1.0% Senior Convertible Debentures due in 2035 (the “1.0% 2035 Debentures”) in a private placement. We used a portion of the proceeds to repurchase $38.3 million in aggregate principal on our 2.75% Senior Convertible Debentures due in 2031 and to repay the aggregate principal balance of $472.5 million on the term loan. Upon the repurchase and repayment of debts in December 2015, we recorded an extinguishment loss of $4.9 million in other expense, net , in the accompanying consolidated statements of operations. The 1.0% 2035 Debentures bear interest at 1.0% per year, payable in cash semi-annually in arrears. The 1.0% 2035 Debentures mature on December 15, 2035 , subject to the right of the holders to require us to redeem the 1.0% 2035 Debentures on December 15, 2022, 2027, or 2032 . The 1.0% 2035 Debentures are general senior unsecured obligations and rank equally in right of payment with all of our existing and future unsecured, unsubordinated indebtedness and senior in right of payment to any indebtedness that is contractually subordinated to the 1.0% 2035 Debentures. The 1.0% 2035 Debentures will be effectively subordinated to indebtedness and other liabilities of our subsidiaries. The initial conversion price is approximately $27.22 per share. At issuance, we allocated $495.4 million to long-term debt, and $181.1 million has been recorded as additional paid-in capital, which is being amortized to interest expense using the effective interest rate method through December 2022 . As of December 31, 2017 , none of the conversion criteria were met for the 1.0% 2035 Debentures. If the conversion criteria were met, we could be required to repay all or some of the aggregate principal amount in cash prior to the maturity date. 2.75% Convertible Debentures due 2031 In October 2011 , we issued $690.0 million in aggregate principal amount of 2.75% Senior Convertible Debentures due in 2031 (the “2031 Debentures”) in a private placement. The 2031 Debentures bear interest at 2.75% per year, payable in cash semi-annually in arrears. The 2031 Debentures mature on November 1, 2031 , subject to the right of the holders to require us to redeem the 2031 Debentures on November 1, 2017, 2021, and 2026 . The 2031 Debentures are general senior unsecured obligations and rank equally in right of payment with all of our existing and future unsecured, unsubordinated indebtedness and senior in right of payment to any indebtedness that is contractually subordinated to the 2031 Debentures. The 2031 Debentures will be effectively subordinated to indebtedness and other liabilities of our subsidiaries. The initial conversion price is approximately $32.30 per share. At issuance, we allocated $533.6 million to long-term debt, and $156.4 million has been recorded as additional paid-in capital, which is being amortized to interest expense using the effective interest rate method through November 2017 . In June 2015, we entered into separate privately negotiated agreements with certain holders of our 2031 Debentures to exchange, in a private placement, $256.2 million in aggregate principal amount of our 2031 Debentures for approximately $263.9 million in aggregate principal amount of our 1.5% 2035 Debentures. In December 2015, we entered into separate privately negotiated agreements with certain holders of our 2031 Debentures to repurchase $38.3 million in aggregate principal with proceeds received from the issuance of our 1.0% 2035 Debentures. In March 2017, we entered into separate privately negotiated agreements with certain holders of our 2031 Debentures to repurchase $17.8 million in aggregate principal with proceeds received from the issuance of our 1.25% Senior Convertible Debentures issued in March 2017. Following these activities, $377.7 million in aggregate principal amount of our 2031 Debentures remained outstanding as of September 30, 2017 , which was included within the total current liabilities. In November 2017, holders of approximately $331.2 million in aggregate principal amount of the outstanding 2031 Debentures exercised their right to require us to repurchase such debentures. Following the repurchase, $46.6 million in aggregate principal amount of the 2031 Debentures remains outstanding. On or after November 6, 2017, we have the right to call for redemption of some or all of the remaining outstanding 2031 Debentures. 1.25% Convertible Debentures due 2025 In March 2017, we issued $350.0 million in aggregate principal amount of 1.25% Senior Convertible Debentures due in 2025 (the “1.25% 2025 Debentures”) in a private placement. The proceeds were approximately $343.6 million , net of issuance costs. We used a portion of the proceeds to repurchase 5.8 million shares of our common stock for $99.1 million and $17.8 million in aggregate principal on our 2031 Debentures. We used the remaining net proceeds, together with cash on hand to redeem and retire $331.2 million of our outstanding 2031 Debentures in November 2017. The 1.25% 2025 Debentures bear interest at 1.25% per year, payable in cash semi-annually in arrears, beginning on October 1, 2017. The 1.25% 2025 Debentures mature on April 1, 2025. The 1.25% 2025 Debentures are general senior unsecured obligations and rank equally in right of payment with all of our existing and future unsecured, unsubordinated indebtedness and senior in right of payment to any indebtedness that is contractually subordinated to the 1.25% 2025 Debentures. The 1.25% 2025 Debentures will be effectively subordinated to indebtedness and other liabilities of our subsidiaries. We account separately for the liability and equity components of the 1.25% 2025 Debentures in accordance with authoritative guidance for convertible debt instruments that may be settled in cash upon conversion. The guidance requires the carrying amount of the liability component to be estimated by measuring the fair value of a similar liability that does not have an associated conversion feature and record the remainder in stockholders’ equity. At issuance, we allocated $252.1 million to long-term debt, and $97.9 million has been recorded as additional paid-in capital, which is being amortized to interest expense using the effective interest rate method through April 1, 2025. If converted, the principal amount of the 1.25% 2025 Debentures is payable in cash and any amounts payable in excess of the principal amount will (based on an initial conversion rate, which represents an initial conversion price of approximately $22.22 per share, subject to adjustment under certain circumstances) be paid in cash or shares of our common stock, at our election, only in the following circumstances and to the following extent: (i) prior to October 1, 2024, on any date during any fiscal quarter beginning after June 30, 2017 (and only during such fiscal quarter) if the closing sale price of our common stock was more than 130% of the then current conversion price for at least 20 trading days in the period of the 30 consecutive trading days ending on the last trading day of the previous fiscal quarter; (ii) at any time on or after October 1, 2024, (iii) during the five consecutive business-day period immediately following any five consecutive trading-day period in which the trading price for $1,000 principal amount of the 1.25% 2025 Debentures for each day during such five trading-day period was less than 98% of the closing sale price of our common stock multiplied by the then current conversion rate; or (iv) upon the occurrence of specified corporate transactions, as described in the indenture for the 1.25% 2025 Debentures. We may not redeem the 1.25% 2025 Debentures prior to the maturity date. If we undergo a fundamental change or non-stock change of control (as described in the indenture for the 1.25% 2025 Debentures) prior to maturity, holders will have the option to require us to repurchase all or any portion of their debentures for cash at a price equal to 100% of the principal amount of the 1.25% 2025 Debentures to be purchased plus any accrued and unpaid interest, including any additional interest to, but excluding, the repurchase date. As of December 31, 2017 , none of the conversion criteria were met for the 1.25% 2025 Debentures. If the conversion criteria were met, we could be required to repay all or some of the aggregate principal amount in cash prior to the maturity date. 1.50% Convertible Debentures due 2035 In June 2015, we issued $263.9 million in aggregate principal amount of 1.50% Senior Convertible Debentures due in 2035 (the “1.5% 2035 Debentures”) in exchange for $256.2 million in aggregate principal amount of our 2031 Debentures. The 1.5% 2035 Debentures were issued at 97.09% of the principal amount, which resulted in a discount of $7.7 million . The 1.5% 2035 Debentures bear interest at 1.50% per year, payable in cash semi-annually in arrears. The 1.5% 2035 Debentures mature on November 1, 2035, subject to the right of the holders to require us to redeem the 1.5% 2035 Debentures on November 1, 2021, 2026, or 2031. The 1.5% 2035 Debentures are general senior unsecured obligations and rank equally in right of payment with all of our existing and future unsecured, unsubordinated indebtedness and senior in right of payment to any indebtedness that is contractually subordinated to the 1.5% 2035 Debentures. The 1.5% 2035 Debentures will be effectively subordinated to indebtedness and other liabilities of our subsidiaries. The initial conversion price is approximately $23.26 per share. At issuance, we allocated $208.6 million to long-term debt, and $55.3 million has been recorded as additional paid-in capital, which is being amortized to interest expense using the effective interest rate method through November 2021. As of December 31, 2017 , none of the conversion criteria were met for the 1.5% 2035 Debentures. If the conversion criteria were met, we could be required to repay all or some of the aggregate principal amount in cash prior to the maturity date. Revolving Credit Facility Our revolving credit agreement (the “Revolving Credit Facility”), which expires on April 15, 2021, provides for aggregate borrowing commitments of $242.5 million , including the revolving facility loans, the swingline loans and issuance of letters of credit. As of December 31, 2017 , after taking into account the outstanding letters of credit of $4.5 million , we had $238.0 million available for additional borrowing under the Revolving Credit Facility. The borrowing outstanding under the Revolving Credit Facility bears interest at either (i) LIBOR plus an applicable margin of 1.50% or 1.75% , or (ii) the alternative base rate plus an applicable margin of 0.50% or 0.75% . The Revolving Credit Facility is secured by substantially all our assets. The Revolving Credit Facility contains customary affirmative and negative covenants and conditions to borrowing, as well as customary events of default. As of December 31, 2017 , we are in compliance with all the debt covenants. |
Stockholders' Equity Stockholde
Stockholders' Equity Stockholders' Equity (Notes) | 3 Months Ended |
Dec. 31, 2017 | |
Stockholders' Equity Attributable to Parent [Abstract] | |
Stockholders' Equity Note Disclosure [Text Block] | Stockholders' Equity Share Repurchases On April 29, 2013 , our Board of Directors approved a share repurchase program for up to $500.0 million of our outstanding shares of common stock. On April 29, 2015, our Board of Directors approved an additional $500.0 million under our share repurchase program. Under the terms of the share repurchase program, we have the ability to repurchase shares from time to time through a variety of methods, which may include open market purchases, privately negotiated transactions, block trades, accelerated stock repurchase transactions, or any combination of such methods. The share repurchase program does not require us to acquire any specific number of shares and may be modified, suspended, extended or terminated by us at any time without prior notice. The timing and the amount of any purchases will be determined by management based on an evaluation of market conditions, capital allocation alternatives, and other factors. There were no share repurchases for the three months ended December 31, 2017 or 2016. Since the commencement of the program, we have repurchased an aggregate of 46.5 million shares for $806.6 million . The amount paid in excess of par value is recognized in additional paid in capital. Shares were retired upon repurchase. As of December 31, 2017 , approximately $193.4 million remained available for future repurchases under the program. |
Net Income (Loss) Per Share
Net Income (Loss) Per Share | 3 Months Ended |
Dec. 31, 2017 | |
Earnings Per Share, Basic and Diluted [Abstract] | |
Net (Loss) Income Per Share | Net Income (Loss) Per Share The following table sets forth the computation for basic and diluted net income (loss) per share (dollars in thousands, except per share amounts): Three Months Ended December 31, 2017 2016 Numerator: Net income (loss) $ 53,228 $ (23,929 ) Denominator: Weighted average common shares outstanding - Basic 291,367 288,953 Dilutive effect of employee stock compensation plans 4,628 — Weighted average common shares outstanding — diluted 295,995 288,953 Net income (loss) per share: Basic $ 0.18 $ (0.08 ) Diluted $ 0.18 $ (0.08 ) For the three months ended December 31, 2017 and 2016 , respectively, 0.1 million and 7.1 million shares of anti-dilutive equity instruments issued under our employee stock compensation plans were excluded from the computation of diluted net income (loss) per share. 2.2 million and 2.8 million shares of contingently issuable awards were excluded from the determination of dilutive net income per share as the conditions were not met if the end of the reporting period would be the end of the performance period. For the three months ended December 31, 2016, there was no dilutive effect of equity instruments as the impact of these items was anti-dilutive due to the net loss incurred during the period. |
Stock-Based Compensation
Stock-Based Compensation | 3 Months Ended |
Dec. 31, 2017 | |
Share-based Compensation [Abstract] | |
Stock-Based Compensation | Stock-Based Compensation We recognize stock-based compensation expense over the requisite service period. Our share-based awards are classified within equity. The amounts included in the condensed consolidated statements of operations relating to stock-based compensation are as follows (dollars in thousands): Three Months Ended December 31, 2017 2016 Cost of professional services and hosting $ 7,407 $ 8,410 Cost of product and licensing 266 92 Cost of maintenance and support 1,204 977 Research and development 9,696 8,490 Sales and marketing 10,676 11,969 General and administrative 8,737 9,192 Total $ 37,986 $ 39,130 Stock Options The table below summarizes activities related to stock options for the three months ended December 31, 2017 : Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value (a) Outstanding at September 30, 2017 23,807 $ 15.39 Exercised (1,859 ) $ 3.41 Outstanding at December 31, 2017 21,948 $ 16.40 2.8 years $ 0.1 million Exercisable at December 31, 2017 21,939 $ 16.41 2.8 years $ 0.1 million Exercisable at December 31, 2016 1,050,038 $ 16.29 1.0 year $ 0.2 million (a) The aggregate intrinsic value in this table represents any excess of the closing market price of our common stock as of December 31, 2017 ( $16.35 ) over the exercise price of the underlying options. The aggregate intrinsic value of stock options exercised during the three months ended December 31, 2017 and 2016 was $0.02 million and $0.7 million , respectively. Restricted Units Restricted units are not included in issued and outstanding common stock until the shares are vested and released. The purchase price for vested restricted units is $0.001 per share. The table below summarizes activities relating to restricted units for the three months ended December 31, 2017 : Number of Shares Underlying Restricted Units — Contingent Awards Number of Shares Underlying Restricted Units — Time-Based Awards Outstanding at September 30, 2017 5,043,931 6,477,164 Granted 688,999 4,263,946 Earned/released (1,687,862 ) (3,614,185 ) Forfeited (893,287 ) (168,642 ) Outstanding at December 31, 2017 3,151,781 6,958,283 Weighted average remaining recognition period of outstanding restricted units 1.2 years 1.8 years Unrecognized stock-based compensation expense of outstanding restricted units $45.0 million $79.8 million Aggregate intrinsic value of outstanding restricted units (a) $51.5 million $113.9 million (a) The aggregate intrinsic value in this table represents any excess of the closing market price of our common stock as of December 31, 2017 ( $16.35 ) over the purchase price of the underlying restricted units. A summary of the weighted-average grant-date fair value of restricted units granted, and the aggregate intrinsic value of restricted units vested during the periods noted is as follows: Three Months Ended December 31, 2017 2016 Weighted-average grant-date fair value per share $ 14.92 $ 15.90 Total intrinsic value of shares vested (in millions) $ 84.7 $ 88.3 |
Income Taxes
Income Taxes | 3 Months Ended |
Dec. 31, 2017 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The components of loss before income taxes are as follows (dollars in thousands): Three Months Ended December 31, 2017 2016 Domestic $ (40,031 ) $ (47,583 ) Foreign 14,738 34,007 Loss before income taxes $ (25,293 ) $ (13,576 ) The components of (benefit) provision for income taxes are as follows (dollars in thousands): Three Months Ended December 31, 2017 2016 Domestic $ (80,866 ) $ 4,159 Foreign 2,345 6,194 (Benefit) provision for income taxes $ (78,521 ) $ 10,353 Effective tax rate 310.4 % (76.3 )% On December 22, 2017, the Tax Cuts and Jobs Act ("TCJA") was signed into law. The TCJA significantly revises the U.S. corporate income tax by, among other things, lowering corporate income tax rates, implementing a hybrid territorial tax system, and imposing a one-time repatriation tax on foreign cash and earnings. We are currently assessing the impact of the realization of deferred tax assets, remeasurement of deferred taxes at lower rates, and the provision for a one-time repatriation tax. Based on our preliminary assessment, we recorded a provisional amount of income tax benefit for the three months ended December 31, 2017, reflecting a benefit of approximately $96 million related to changes in the carrying value of certain deferred tax assets and liabilities, offset in part by an expense of approximately $14 million related to deemed repatriation of foreign cash and earnings. The provisional amounts above were based upon the estimate of (i) temporary differences at the end of the upcoming tax year, (ii) the timing of the temporary differences expected to reverse, (iii) foreign earnings and profits, and (iv) foreign income taxes. The assessment is incomplete as of December 31, 2017. As our assessment is ongoing, these amounts may materially change as we revise our assumptions and estimates based on new information available to us, changes in our interpretations, additional guidance to be issued, and actions we may take as a result of the TCJA. Additionally, we are still evaluating the full impact of other provisions of the TCJA, which may materially increase or decrease our income tax provision. The assessment is expected to be completed no later than the first quarter of fiscal year 2019. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Dec. 31, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Litigation and Other Claims Similar to many companies in the software industry, we are involved in a variety of claims, demands, suits, investigations and proceedings that arise from time to time relating to matters incidental to the ordinary course of our business, including at times actions with respect to contracts, intellectual property, employment, benefits and securities matters. At each balance sheet date we evaluate contingent liabilities associated with these matters in accordance with ASC 450 “Contingencies.” If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, we accrue a liability for the estimated loss. Significant judgments are required for the determination of probability and the range of the outcomes, and estimates are based only on the best information available at the time. Due to the inherent uncertainties involved in claims and legal proceedings and in estimating losses that may arise, actual outcomes may differ from our estimates. Contingencies deemed not probable or for which losses were not estimable in one period may become probable, or losses may become estimable in later periods, which may have a material impact on our results of operations and financial position. As of December 31, 2017 , accrued losses were not material to our condensed consolidated financial statements, and we do not expect any pending matter to have a material impact on our condensed consolidated financial statements. Guarantees and Other We include indemnification provisions in the contracts we enter with customers and business partners. Generally, these provisions require us to defend claims arising out of our products’ infringement of third-party intellectual property rights, breach of contractual obligations and/or unlawful or otherwise culpable conduct. The indemnity obligations generally cover damages, costs and attorneys’ fees arising out of such claims. In most, but not all cases, our total liability under such provisions is limited to either the value of the contract or a specified, agreed upon amount. In some cases, our total liability under such provisions is unlimited. In many, but not all cases, the term of the indemnity provision is perpetual. While the maximum potential amount of future payments we could be required to make under all the indemnification provisions is unlimited, we believe the estimated fair value of these provisions is minimal due to the low frequency with which these provisions have been triggered. We indemnify our directors and officers to the fullest extent permitted by Delaware law, which provides among other things, indemnification to directors and officers for expenses, judgments, fines, penalties and settlement amounts incurred by such persons in their capacity as a director or officer of the company, regardless of whether the individual is serving in any such capacity at the time the liability or expense is incurred. Additionally, in connection with certain acquisitions, we agreed to indemnify the former officers and members of the boards of directors of those companies, on similar terms as described above, for a period of six years from the acquisition date. In certain cases, we purchase director and officer insurance policies related to these obligations, which fully cover the six -year period. To the extent that we do not purchase a director and officer insurance policy for the full period of any contractual indemnification, and such directors and officers do not have coverage under separate insurance policies, we would be required to pay for costs incurred, if any, as described above. |
Segment and Geographic Informat
Segment and Geographic Information and Significant Customers | 3 Months Ended |
Dec. 31, 2017 | |
Segment Reporting [Abstract] | |
Segment and Geographic Information and Significant Customers | Segment and Geographic Information During the first quarter of fiscal year 2018, we commenced a reorganization of our segment reporting structure based on the growth of each business and the evolving industry vertical in which it participates. Such reorganization will allow our Chief Operating Decision Maker ("CODM") greater focus on implementing strategic initiatives and identifying future investment opportunities. In January 2018, we publicly announced that, in addition to the previously communicated intent to establish the automotive business as a separate reportable segment and business line, we will also merge the Communications Service Provider (CSP, or Mobile Operator Services) business line into the Enterprise segment to form a consolidated focus on our business in the telecommunications market. In connection with the ongoing reorganization, we are currently implementing changes to our reporting processes to facilitate operating segment reporting. As a transition, during the first quarter of fiscal year 2018, segment information compiled and presented to our CODM still reflects the existing segment structure. As a result, segment information for the three months ended December 31, 2017 and 2016 below was presented in manner consistent with the level of discrete financial information included within our CODM review package. We expect that the reorganization efforts will be completed in the second quarter of fiscal year 2018, and the presentation of our segment information will reflect the reorganized segment reporting structure upon completion of the reorganization. Additionally, we are continuing the process of identifying and assessing other initiatives to better align our segment reporting structure with our long-term strategies. Our CODM regularly reviewed segment revenues and segment profits for performance evaluation and resources allocation. Segment revenues include certain acquisition-related adjustments for revenues that would otherwise have been recognized without the acquisition. Segment profits reflect controllable costs directly related to each segment and the allocation of certain corporate expenses such as, corporate sales and marketing expenses and research and development project costs that benefit multiple segments. Certain items such as stock-based compensation, amortization of intangible assets, acquisition-related costs, net, restructuring and other charges, net, other expenses, net and certain unallocated corporate expenses are excluded from segment profits, which allow for more meaningful comparisons to the financial results of the historical operations for the performance evaluation and resources allocation by our CODM. • The Healthcare segment is primarily engaged in clinical speech and clinical language understanding solutions that improve the clinical documentation process, from capturing the complete patient record to improving clinical documentation and quality measures for reimbursement. • The Mobile segment is primarily engaged in providing a broad portfolio of specialized virtual assistants and connected services built on voice recognition, text-to-speech, natural language understanding, dialog, and text input technologies. • The Enterprise segment is primarily engaged in using speech, natural language understanding, and artificial intelligence to provide automated customer solutions and services for voice, mobile, web and messaging channels. • The Imaging segment is primarily engaged in software solutions and expertise that help professionals and organizations to gain optimal control of their document and information processes through scanning and print management. We do not track our assets by operating segment. Consequently, it is not practical to show assets or depreciation by operating segment. The following table presents segment results along with a reconciliation of segment profit to loss before income taxes (dollars in thousands): Three Months Ended December 31, 2017 2016 Segment revenues : Healthcare $ 245,535 $ 239,208 Mobile 89,829 91,784 Enterprise 117,831 112,938 Imaging 55,630 52,089 Total segment revenues 508,825 496,019 Less: acquisition-related revenues adjustments (7,180 ) (8,361 ) Total revenues 501,645 487,658 Segment profit: Healthcare 77,419 78,567 Mobile 25,423 33,471 Enterprise 38,935 31,958 Imaging 15,643 17,616 Total segment profit 157,420 161,612 Corporate expenses and other, net (44,665 ) (30,959 ) Acquisition-related revenues (7,180 ) (8,361 ) Stock-based compensation (37,986 ) (39,130 ) Amortization of intangible assets (38,420 ) (43,401 ) Acquisition-related costs, net (5,561 ) (9,026 ) Restructuring and other charges, net (14,801 ) (6,703 ) Other expenses, net (34,100 ) (37,608 ) Loss before income taxes $ (25,293 ) $ (13,576 ) No country outside of the United States provided greater than 10% of our total revenues. Revenues, classified by the major geographic areas in which our customers are located, were as follows (dollars in thousands): Three Months Ended December 31, 2017 2016 United States $ 364,286 $ 349,170 International 137,359 138,488 Total revenues $ 501,645 $ 487,658 |
Summary of Significant Accoun23
Summary of Significant Accounting Policies Recently Issued Accounting Pronouncements (Tables) | 3 Months Ended |
Dec. 31, 2017 | |
Recently Issued Accounting Pronouncements [Abstract] | |
New Accounting Pronouncements, Policy [Policy Text Block] | Recently Issued Accounting Standards In August 2016, the FASB issued ASU 2016-15, "Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments" ("ASU 2016-15"), which is effective for fiscal years beginning after December 15, 2017 and the interim periods therein, with early adoption permitted. The guidance requires cash flows with multiple characteristics to be classified using a three-step process, including (i) determining whether explicit guidance is applicable, (ii) separating each identifiable source or use of cash flows, and (iii) determining the predominant source or use of cash flows when the source or use of cash flows cannot be separately identifiable. We are still evaluating the impact of the guidance on our consolidated financial statement. In February 2016, the FASB issued ASU No. 2016-02, "Leases" ("ASU 2016-02"). ASU 2016-02 requires lessees to recognize on the balance sheet a right-of-use asset, representing its right to use the underlying asset for the lease term, and a lease liability for all leases with terms greater than 12 months. The guidance also requires qualitative and quantitative disclosures designed to assess the amount, timing, and uncertainty of cash flows arising from leases. The standard requires the use of a modified retrospective transition approach, which includes a number of optional practical expedients that entities may elect to apply. ASU 2016-02 is effective for us in the first quarter of fiscal year 2020, and early application is permitted. We are currently evaluating the impact of our pending adoption of ASU 2016-02 on our consolidated financial statements, and we currently expect that most of our operating lease commitments will be subject to the new standard and recognized as operating lease liabilities and right-of-use assets upon our adoption of ASU 2016-02, which will increase our total assets and total liabilities that we report relative to such amounts prior to adoption. In January 2016, the FASB issued ASU No. 2016-01, "Recognition and Measurement of Financial Assets and Financial Liabilities" ("ASU 2016-01"). ASU 2016-01 amends the guidance on the classification and measurement of financial instruments. Although ASU 2016-01 retains many current requirements, it significantly revises accounting related to the classification and measurement of investments in equity securities and the presentation of certain fair value changes for financial liabilities measured at fair value. ASU 2016-01 also amends certain disclosure requirements associated with the fair value of financial instruments and is effective for us in the first quarter of fiscal year 2019. Based on the composition of our investment portfolio, we do not believe the adoption of ASU 2016-01 will have a material impact on our consolidated financial statements. In May 2014, the FASB issued ASU No. 2014-09, "Revenue from Contracts with Customers: Topic 606" ("ASU 2014-09"), to supersede nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. ASU 2014-09 defines a five-step process to achieve this core principle and, in doing so, it is possible more judgment and estimates may be required within the revenue recognition process than required under existing U.S. GAAP including identifying performance obligations in the contract, estimating the amount of variable consideration to include in the transaction price and allocating the transaction price to each separate performance obligation. ASU 2014-09 permits two methods of adoption: (i) retrospective to each prior reporting period presented; or (ii) retrospective with the cumulative effect of initially applying the guidance recognized at the date of initial application. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers: Deferral of the Effective Date, which deferred the effective date of the new revenue standard for periods beginning after December 15, 2016 to December 15, 2017, with early adoption permitted but not earlier than the original effective date. Accordingly, the updated standard is effective for us in the first quarter of fiscal 2019 and we do not plan to early adopt. In the first quarter of fiscal 2017, we commenced a project to assess the potential impact of the new standard on our consolidated financial statements and related disclosures. This project also includes the assessment and enhancement of our internal processes and systems to address the new standard. While we are continuing to assess all potential impacts of the new standard, we currently believe the most significant impact relates to our accounting for arrangements that include term-based software licenses bundled with maintenance and support. Under current GAAP, the revenue attributable to these software licenses is recognized ratably over the term of the arrangement because vendor-specific objective evidence ("VSOE") does not exist for the undelivered maintenance and support element as it is not sold separately. The requirement to have VSOE for undelivered elements to enable the separation of revenue for the delivered software licenses is eliminated under the new standard. Accordingly, under the new standard we will be required to recognize as revenue a portion of the arrangement fee upon delivery of the software license. While we currently expect revenue related to our professional services and cloud offerings to remain substantially unchanged, we are still in the process of evaluating the impact of the new standard on these arrangements. We plan to adopt this guidance beginning on October 1, 2018 and apply the cumulative catch-up transition method, with a cumulative adjustment to retained earnings as opposed to retrospectively adjusting prior periods. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets (Tables) | 3 Months Ended |
Dec. 31, 2017 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Changes in Carrying Amount of Goodwill and Intangible Assets | The changes in the carrying amount of goodwill and intangible assets for the three months ended December 31, 2017 are as follows (dollars in thousands): Goodwill Intangible Assets Balance at September 30, 2017 $ 3,590,608 $ 664,474 Acquisitions (Note 3) 6,790 2,000 Purchase accounting adjustments (348 ) — Amortization — (38,420 ) Effect of foreign currency translation 3,718 (498 ) Balance at December 31, 2017 $ 3,600,768 $ 627,556 |
Financial Instruments and Hed25
Financial Instruments and Hedging Activities (Tables) | 3 Months Ended |
Dec. 31, 2017 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Quantitative Summary of Fair Value of Derivative Instruments | A summary of the derivative instruments as of December 31, 2017 and September 30, 2017 is as follows (dollars in thousands): Derivatives Not Designated as Hedges: Balance Sheet Classification Fair Value December 31, September 30, Foreign currency forward contracts Prepaid expenses and other current assets $ 535 $ 220 Foreign currency forward contracts Accrued expenses and other current liabilities (65 ) (373 ) |
Summarized Activity of Derivative Instruments | A summary of loss related to the derivative instruments for the three months ended December 31, 2017 and 2016 is as follows (dollars in thousands): Three Months Ended December 31, Derivatives Not Designated as Hedges Classification of Loss Recognized in Income 2017 2016 Foreign currency forward contracts Other expense, net $ (397 ) $ (11,615 ) |
Fair Value Measures (Tables)
Fair Value Measures (Tables) | 3 Months Ended |
Dec. 31, 2017 | |
Fair Value Disclosures [Abstract] | |
Assets and Liabilities Measured at Fair Value on Recurring Basis | Assets and liabilities measured at fair value on a recurring basis at December 31, 2017 and September 30, 2017 consisted of the following (dollars in thousands): December 31, 2017 Level 1 Level 2 Level 3 Total Assets: Money market funds (a) $ 245,036 $ — $ — $ 245,036 Time deposits (b) — 99,774 — 99,774 Commercial paper, $38,069 at cost (b) — 38,182 — 38,182 Corporate notes and bonds, $83,827 at cost (b) — 83,532 — 83,532 Foreign currency exchange contracts (b) — 535 — 535 Total assets at fair value $ 245,036 $ 222,023 $ — $ 467,059 Liabilities: Foreign currency exchange contracts (b) $ — $ (65 ) $ — $ (65 ) Contingent acquisition payments (c) — — (10,431 ) (10,431 ) Total liabilities at fair value $ — $ (65 ) $ (10,431 ) $ (10,496 ) September 30, 2017 Level 1 Level 2 Level 3 Total Assets: Money market funds (a) $ 381,899 $ — $ — $ 381,899 Time deposits (b) — 85,570 — 85,570 Commercial paper, $41,805 at cost (b) — 41,968 — 41,968 Corporate notes and bonds, $74,150 at cost (b) — 74,067 — 74,067 Foreign currency exchange contracts (b) — 220 — 220 Total assets at fair value $ 381,899 $ 201,825 $ — $ 583,724 Liabilities: Foreign currency exchange contracts (b) $ — $ (373 ) $ — $ (373 ) Contingent acquisition payments (c) — — (8,648 ) (8,648 ) Total liabilities at fair value $ — $ (373 ) $ (8,648 ) $ (9,021 ) |
Changes in Fair Value of Contingent Earn-Out Liabilities | The following table provides a summary of changes in the aggregate fair value of the contingent acquisition payments for the three months ended December 31, 2017 and 2016 (dollars in thousands): Three Months Ended December 31, 2017 2016 Balance at beginning of period $ 8,648 $ 8,240 Earn-out liabilities established at time of acquisition 500 1,653 Payments and foreign currency translation (17 ) (1,498 ) Adjustments to fair value included in acquisition-related costs, net 1,300 566 Balance at end of period $ 10,431 $ 8,961 |
Accrued Expenses and Other Cu27
Accrued Expenses and Other Current Liabilities (Tables) | 3 Months Ended |
Dec. 31, 2017 | |
Payables and Accruals [Abstract] | |
Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consisted of the following (dollars in thousands): December 31, September 30, Compensation $ 103,991 $ 159,951 Cost of revenue related liabilities 22,066 20,124 Accrued interest payable 21,733 26,285 Consulting and professional fees 19,274 12,649 Facilities related liabilities 5,540 7,158 Sales and marketing incentives 4,190 3,655 Sales and other taxes payable 3,190 3,125 Other 13,422 12,954 Total $ 193,406 $ 245,901 |
Deferred Revenue (Tables)
Deferred Revenue (Tables) | 3 Months Ended |
Dec. 31, 2017 | |
Deferred Revenue [Abstract] | |
Deferred Revenue | Deferred revenue consisted of the following (dollars in thousands): December 31, September 30, Current liabilities: Deferred maintenance revenue $ 171,980 $ 162,958 Unearned revenue 255,561 203,084 Total current deferred revenue $ 427,541 $ 366,042 Long-term liabilities: Deferred maintenance revenue $ 62,494 $ 60,298 Unearned revenue 390,612 363,631 Total long-term deferred revenue $ 453,106 $ 423,929 |
Restructuring and Other Charg29
Restructuring and Other Charges, net (Tables) | 3 Months Ended |
Dec. 31, 2017 | |
Restructuring and Related Activities [Abstract] | |
Accrual Activity Relating to Restructuring and Other Charges | The following table sets forth accrual activity relating to restructuring reserves for the three months ended December 31, 2017 (dollars in thousands): Personnel Facilities Total Balance at September 30, 2017 $ 1,546 $ 9,159 $ 10,705 Restructuring charges, net 4,883 1,665 6,548 Non-cash adjustment — (298 ) (298 ) Cash payments (5,392 ) (1,753 ) (7,145 ) Balance at December 31, 2017 $ 1,037 $ 8,773 $ 9,810 |
Restructuring and Other Charges, Net by Segment | Three Months Ended December 31, 2017 2016 Personnel Facilities Total Restructuring Other Charges Total Personnel Facilities Total Restructuring Other Charges Total Healthcare $ 2,513 $ 25 $ 2,538 $ — $ 2,538 $ 1,984 $ 277 $ 2,261 $ — $ 2,261 Mobile 400 11 411 — 411 213 — 213 — 213 Enterprise 262 2,360 2,622 — 2,622 424 607 1,031 — 1,031 Imaging 1,223 9 1,232 — 1,232 361 351 712 — 712 Corporate 485 (740 ) (255 ) 8,253 7,998 669 664 1,333 1,153 2,486 Total $ 4,883 $ 1,665 $ 6,548 $ 8,253 $ 14,801 $ 3,651 $ 1,899 $ 5,550 $ 1,153 $ 6,703 |
Debt and Credit Facilities (Tab
Debt and Credit Facilities (Tables) | 3 Months Ended |
Dec. 31, 2017 | |
Debt Disclosure [Abstract] | |
Schedule of Maturities of Long-term Debt [Table Text Block] | The following table summarizes the maturities of our borrowing obligations as of December 31, 2017 (dollars in thousands): Fiscal Year Convertible Debentures (1) Senior Notes Total 2018 $ — $ — $ — 2019 — — — 2020 — 450,000 450,000 2021 — — — 2022 310,463 — 310,463 Thereafter 1,026,488 800,000 1,826,488 Total before unamortized discount 1,336,951 1,250,000 2,586,951 Less: unamortized discount and issuance costs (277,455 ) (9,902 ) (287,357 ) Total long-term debt $ 1,059,496 $ 1,240,098 $ 2,299,594 (1) Pursuant to the terms of each convertible instrument, holders have the right to redeem the debt on specific dates prior to maturity. The repayment schedule above assumes that payment is due on the next redemption date after December 31, 2017 . |
Borrowing Obligations and Applicable Margin for Borrowings | At December 31, 2017 and September 30, 2017 , we had the following long-term borrowing obligations (dollars in thousands): December 31, September 30, 5.625% Senior Notes due 2026, net of deferred issuance costs of $5.5 million and $5.7 million, respectively. Effective interest rate 5.625%. $ 494,453 $ 494,298 5.375% Senior Notes due 2020, net of unamortized premium of $0.9 million and $1.0 million, respectively, and deferred issuance costs of $2.1 million and $2.3 million, respectively. Effective interest rate 5.375%. 448,748 448,630 6.000% Senior Notes due 2024, net of deferred issuance costs of $2.0 million and $2.1 million, respectively. Effective interest rate 6.000%. 297,988 297,910 1.00% Convertible Debentures due 2035, net of unamortized discount of $135.0 million and $140.9 million, respectively, and deferred issuance costs of $6.6 million and $6.9 million, respectively. Effective interest rate 5.622%. 534,885 528,690 2.75% Convertible Debentures due 2031, net of unamortized discount of $1.5 million and deferred issuance costs of $0.1 million as of September 30, 2017. Effective interest rate 7.432%. 46,568 376,121 1.25% Convertible Debentures due 2025, net of unamortized discount of $90.2 million and $92.7 million, respectively, and deferred issuance costs of $4.1 million and $4.3 million, respectively. Effective interest rate 5.578%. 255,703 253,054 1.50% Convertible Debentures due 2035, net of unamortized discount of $40.1 million and $42.5 million, respectively, and deferred issuance costs of $1.4 million and $1.5 million, respectively. Effective interest rate 5.394%. 222,340 219,875 Deferred issuance costs related to our Revolving Credit Facility (1,091 ) (1,174 ) Total debt 2,299,594 2,617,404 Less: current portion — 376,121 Total long-term debt $ 2,299,594 $ 2,241,283 |
Net Income (Loss) Per Share (Ta
Net Income (Loss) Per Share (Tables) | 3 Months Ended |
Dec. 31, 2017 | |
Net Income (Loss) per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | The following table sets forth the computation for basic and diluted net income (loss) per share (dollars in thousands, except per share amounts): Three Months Ended December 31, 2017 2016 Numerator: Net income (loss) $ 53,228 $ (23,929 ) Denominator: Weighted average common shares outstanding - Basic 291,367 288,953 Dilutive effect of employee stock compensation plans 4,628 — Weighted average common shares outstanding — diluted 295,995 288,953 Net income (loss) per share: Basic $ 0.18 $ (0.08 ) Diluted $ 0.18 $ (0.08 ) |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 3 Months Ended |
Dec. 31, 2017 | |
Share-based Compensation [Abstract] | |
Stock Based Compensation Included in Consolidated Statements of Operations | The amounts included in the condensed consolidated statements of operations relating to stock-based compensation are as follows (dollars in thousands): Three Months Ended December 31, 2017 2016 Cost of professional services and hosting $ 7,407 $ 8,410 Cost of product and licensing 266 92 Cost of maintenance and support 1,204 977 Research and development 9,696 8,490 Sales and marketing 10,676 11,969 General and administrative 8,737 9,192 Total $ 37,986 $ 39,130 |
Summary of Stock Options Activity | The table below summarizes activities related to stock options for the three months ended December 31, 2017 : Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value (a) Outstanding at September 30, 2017 23,807 $ 15.39 Exercised (1,859 ) $ 3.41 Outstanding at December 31, 2017 21,948 $ 16.40 2.8 years $ 0.1 million Exercisable at December 31, 2017 21,939 $ 16.41 2.8 years $ 0.1 million Exercisable at December 31, 2016 1,050,038 $ 16.29 1.0 year $ 0.2 million (a) The aggregate intrinsic value in this table represents any excess of the closing market price of our common stock as of December 31, 2017 ( $16.35 ) over the exercise price of the underlying options. |
Summary of Activity Relating to Restricted Units and Restricted Stock Awards | The table below summarizes activities relating to restricted units for the three months ended December 31, 2017 : Number of Shares Underlying Restricted Units — Contingent Awards Number of Shares Underlying Restricted Units — Time-Based Awards Outstanding at September 30, 2017 5,043,931 6,477,164 Granted 688,999 4,263,946 Earned/released (1,687,862 ) (3,614,185 ) Forfeited (893,287 ) (168,642 ) Outstanding at December 31, 2017 3,151,781 6,958,283 Weighted average remaining recognition period of outstanding restricted units 1.2 years 1.8 years Unrecognized stock-based compensation expense of outstanding restricted units $45.0 million $79.8 million Aggregate intrinsic value of outstanding restricted units (a) $51.5 million $113.9 million (a) The aggregate intrinsic value in this table represents any excess of the closing market price of our common stock as of December 31, 2017 ( $16.35 ) over the purchase price of the underlying restricted units. |
Summary of Weighted-Average Grant-Date Fair Value and Intrinsic Value of Restricted Units and Restricted Stock Awards Vested | A summary of the weighted-average grant-date fair value of restricted units granted, and the aggregate intrinsic value of restricted units vested during the periods noted is as follows: Three Months Ended December 31, 2017 2016 Weighted-average grant-date fair value per share $ 14.92 $ 15.90 Total intrinsic value of shares vested (in millions) $ 84.7 $ 88.3 |
Income Taxes (Tables)
Income Taxes (Tables) | 3 Months Ended |
Dec. 31, 2017 | |
Income Tax Disclosure [Abstract] | |
Components of Benefit from Income Taxes | The components of loss before income taxes are as follows (dollars in thousands): Three Months Ended December 31, 2017 2016 Domestic $ (40,031 ) $ (47,583 ) Foreign 14,738 34,007 Loss before income taxes $ (25,293 ) $ (13,576 ) The components of (benefit) provision for income taxes are as follows (dollars in thousands): Three Months Ended December 31, 2017 2016 Domestic $ (80,866 ) $ 4,159 Foreign 2,345 6,194 (Benefit) provision for income taxes $ (78,521 ) $ 10,353 Effective tax rate 310.4 % (76.3 )% |
Segment and Geographic Inform34
Segment and Geographic Information and Significant Customers (Tables) | 3 Months Ended |
Dec. 31, 2017 | |
Segment Reporting [Abstract] | |
Segment Results Along with Reconciliation of Segment Profit to Income Before Income Taxes | The following table presents segment results along with a reconciliation of segment profit to loss before income taxes (dollars in thousands): Three Months Ended December 31, 2017 2016 Segment revenues : Healthcare $ 245,535 $ 239,208 Mobile 89,829 91,784 Enterprise 117,831 112,938 Imaging 55,630 52,089 Total segment revenues 508,825 496,019 Less: acquisition-related revenues adjustments (7,180 ) (8,361 ) Total revenues 501,645 487,658 Segment profit: Healthcare 77,419 78,567 Mobile 25,423 33,471 Enterprise 38,935 31,958 Imaging 15,643 17,616 Total segment profit 157,420 161,612 Corporate expenses and other, net (44,665 ) (30,959 ) Acquisition-related revenues (7,180 ) (8,361 ) Stock-based compensation (37,986 ) (39,130 ) Amortization of intangible assets (38,420 ) (43,401 ) Acquisition-related costs, net (5,561 ) (9,026 ) Restructuring and other charges, net (14,801 ) (6,703 ) Other expenses, net (34,100 ) (37,608 ) Loss before income taxes $ (25,293 ) $ (13,576 ) |
Classification of Revenue By Major Geographic Areas | Revenues, classified by the major geographic areas in which our customers are located, were as follows (dollars in thousands): Three Months Ended December 31, 2017 2016 United States $ 364,286 $ 349,170 International 137,359 138,488 Total revenues $ 501,645 $ 487,658 |
Summary of Significant Accoun35
Summary of Significant Accounting Policies Recently Adopted Accounting Standards (Details) $ in Millions | 3 Months Ended |
Dec. 31, 2017USD ($) | |
Accounting Policies [Abstract] | |
Other Comprehensive Income (Loss), Tax | $ 0.9 |
Business Acquisitions (Summary
Business Acquisitions (Summary of Preliminary Allocation of Purchase Consideration) (Detail) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2017 | |
Allocation of the purchase consideration: | |||
Closing market value of common stock | $ 16.35 | ||
Contingent And Deferred Acquisition Payments | $ 15,506 | $ 28,860 | |
Other Acquisitions [Member] | |||
Business Acquisition [Line Items] | |||
Payments to Acquire Businesses, Gross | 8,700 | $ 24,200 | |
Allocation of the purchase consideration: | |||
Goodwill | 6,800 | 15,700 | |
Identifiable intangible assets(c) | $ 2,000 | $ 10,400 | |
Weighted Average Useful Life, Intangible Assets Acquired | 2 years | 6 years | |
Contingent And Deferred Acquisition Payments | $ 500 | $ 1,700 |
Business Acquisitions (Componen
Business Acquisitions (Components of Acquisition-Related Costs, Net) (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Business Acquisition [Line Items] | ||
Transition and integration costs | $ 4,062 | $ 3,710 |
Professional service fees | 511 | 5,017 |
Acquisition-related adjustments | 988 | 299 |
Total | $ 5,561 | $ 9,026 |
Changes in Carrying Amount of G
Changes in Carrying Amount of Goodwill and Intangible Assets (Detail) $ in Thousands | 3 Months Ended |
Dec. 31, 2017USD ($) | |
Goodwill [Roll Forward] | |
Balance at September 30, 2017 | $ 3,590,608 |
Goodwill, Acquired During Period | 6,790 |
Goodwill, Purchase Accounting Adjustments | (348) |
Amortization | 0 |
Effect of foreign currency translation | 3,718 |
Balance at December 31, 2017 | 3,600,768 |
Intangible Assets, Net (Excluding Goodwill) [Abstract] | |
Balance at September 30, 2017 | 664,474 |
Finite-lived Intangible Assets Acquired | 2,000 |
Finite-Lived Intangible Assets, Purchase Accounting Adjustments | 0 |
Amortization | (38,420) |
Effect of foreign currency translation | (498) |
Balance at December 31, 2017 | $ 627,556 |
Goodwill and Intangible Asset39
Goodwill and Intangible Assets Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2017 | Sep. 30, 2017 | |
Finite-Lived Intangible Assets [Line Items] | ||
Document Period End Date | Dec. 31, 2017 | |
Finite-lived Intangible Assets Acquired | $ 2,000 | |
Finite-Lived Intangible Assets, Purchase Accounting Adjustments | 0 | |
Goodwill | $ 3,600,768 | $ 3,590,608 |
Financial Instruments and Hed40
Financial Instruments and Hedging Activities (Additional Information) (Detail) - Derivatives Not Designated as Hedges - USD ($) $ in Millions | 3 Months Ended | |
Dec. 31, 2017 | Sep. 30, 2017 | |
Derivative Instruments and Hedging Activities Disclosure [Line Items] | ||
Derivative, Notional Amount | $ 82.4 | $ 69 |
Maximum | ||
Derivative Instruments and Hedging Activities Disclosure [Line Items] | ||
Term of foreign currency forward contracts | 90 days |
Financial Instruments and Hed41
Financial Instruments and Hedging Activities (Quantitative Summary of Fair Value of Derivative Instruments) (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2017 | Sep. 30, 2017 | |
Derivatives, Fair Value [Line Items] | ||
Document Period End Date | Dec. 31, 2017 | |
Foreign currency forward contracts | Prepaid Expenses and Other Current Assets [Member] | ||
Derivatives, Fair Value [Line Items] | ||
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value | $ 535 | $ 220 |
Foreign currency forward contracts | Accrued Expenses And Other Current Liabilities [Member] | ||
Derivatives, Fair Value [Line Items] | ||
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value | $ 65 | $ 373 |
Financial Instruments and Hed42
Financial Instruments and Hedging Activities (Summarized Activity of Derivative Instruments) (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Derivative Instruments, Gain (Loss) [Line Items] | ||
Document Period End Date | Dec. 31, 2017 | |
Derivatives Not Designated as Hedges | Foreign currency forward contracts | Other expense, net | ||
Derivative Instruments, Gain (Loss) [Line Items] | ||
Amount of Gain (Loss) Recognized in Income | $ (397) | $ (11,615) |
Fair Value Measures (Assets and
Fair Value Measures (Assets and Liabilities Measured at Fair Value on Recurring Basis) (Detail) - USD ($) | 3 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2017 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Document Period End Date | Dec. 31, 2017 | ||
Fair Value, Measurements, Recurring | |||
Assets: | |||
Money market funds | $ 245,036,000 | $ 381,899,000 | |
Bank Time Deposits, Fair Value Disclosure | 99,774,000 | 85,570,000 | |
Commercial Paper, Fair value | 38,182,000 | 41,968,000 | |
Corporate notes and bonds, Fair Value | 83,532,000 | 74,067,000 | |
Foreign Currency Contract, Asset, Fair Value Disclosure | 535,000 | 220,000 | |
Total assets at fair value | 467,059,000 | 583,724,000 | |
Foreign Currency Contracts, Liability, Fair Value Disclosure | (65,000) | (373,000) | |
Liabilities: | |||
Contingent earn-out | (10,431,000) | (8,648,000) | |
Total liabilities at fair value | (10,496,000) | (9,021,000) | |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 1 | |||
Assets: | |||
Money market funds | 245,036,000 | 381,899,000 | |
Bank Time Deposits, Fair Value Disclosure | 0 | 0 | |
Commercial Paper, Fair value | 0 | 0 | |
Corporate notes and bonds, Fair Value | 0 | 0 | |
Foreign Currency Contract, Asset, Fair Value Disclosure | 0 | 0 | |
Total assets at fair value | 245,036,000 | 381,899,000 | |
Foreign Currency Contracts, Liability, Fair Value Disclosure | 0 | 0 | |
Liabilities: | |||
Contingent earn-out | 0 | 0 | |
Total liabilities at fair value | 0 | 0 | |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2 | |||
Assets: | |||
Money market funds | 0 | 0 | |
Bank Time Deposits, Fair Value Disclosure | 99,774,000 | 85,570,000 | |
Commercial Paper, Fair value | 38,182,000 | 41,968,000 | |
Corporate notes and bonds, Fair Value | 83,532,000 | 74,067,000 | |
Foreign Currency Contract, Asset, Fair Value Disclosure | 535,000 | 220,000 | |
Total assets at fair value | 222,023,000 | 201,825,000 | |
Foreign Currency Contracts, Liability, Fair Value Disclosure | (65,000) | (373,000) | |
Liabilities: | |||
Contingent earn-out | 0 | 0 | |
Total liabilities at fair value | (65,000) | (373,000) | |
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 3 | |||
Assets: | |||
Money market funds | 0 | 0 | |
Bank Time Deposits, Fair Value Disclosure | 0 | 0 | |
Commercial Paper, Fair value | 0 | 0 | |
Corporate notes and bonds, Fair Value | 0 | 0 | |
Foreign Currency Contract, Asset, Fair Value Disclosure | 0 | 0 | |
Total assets at fair value | 0 | 0 | |
Foreign Currency Contracts, Liability, Fair Value Disclosure | 0 | 0 | |
Liabilities: | |||
Contingent earn-out | (10,431,000) | (8,648,000) | |
Total liabilities at fair value | (10,431,000) | (8,648,000) | |
Corporate Debt Securities [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Available-for-sale Securities, Amortized Cost Basis | 83,827,000 | 74,150,000 | |
Commercial Paper [Member] | |||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |||
Available-for-sale Securities, Amortized Cost Basis | $ 38,069,000 | $ 41,805,000 | |
Commercial paper, corporate notes and bonds [Member] | |||
Liabilities: | |||
Available for sale Securities, Weighted Average Maturity | 8 months 20 days |
Fair Value Measures (Changes in
Fair Value Measures (Changes in Fair Value of Contingent Earn-Out Liabilities) (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||
Document Period End Date | Dec. 31, 2017 | |
Balance at beginning of period | $ 8,648 | $ 8,240 |
Earn-out liabilities established at time of acquisition | 500 | 1,653 |
Payments and foreign currency translation | (17) | |
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements | 1,498 | |
Adjustments to fair value included in acquisition-related costs, net | 1,300 | 566 |
Balance at end of period | 10,431 | $ 8,961 |
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High | $ 25,100 |
Fair Value Measures Fair Value
Fair Value Measures Fair Value Measures - Additional Debt Details (Details) - USD ($) $ in Millions | 12 Months Ended | |
Sep. 30, 2017 | Dec. 31, 2017 | |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Held-to-maturity securities, weighted average maturity | 3 months 9 days | |
Held-to-maturity Securities, Fair Value | $ 80.4 | |
Long-term Debt, Fair Value | 2,930.9 | $ 2,627.2 |
Debt Instrument, Face Amount | 2,918.1 | $ 2,587 |
Corporate Debt Securities [Member] | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Held-to-maturity Securities | $ 80.2 |
Accrued Expenses and Other Cu46
Accrued Expenses and Other Current Liabilities (Detail) - USD ($) $ in Thousands | Dec. 31, 2017 | Sep. 30, 2017 |
Payables and Accruals [Abstract] | ||
Compensation | $ 103,991 | $ 159,951 |
Accrued interest payable | 21,733 | 26,285 |
Cost of revenue related liabilities | 22,066 | 20,124 |
Consulting and professional fees | 19,274 | 12,649 |
Facilities related liabilities | 5,540 | 7,158 |
Sales and marketing incentives | 4,190 | 3,655 |
Sales and other taxes payable | 3,190 | 3,125 |
Other | 13,422 | 12,954 |
Total | $ 193,406 | $ 245,901 |
Deferred Revenue (Detail)
Deferred Revenue (Detail) - USD ($) $ in Thousands | Dec. 31, 2017 | Sep. 30, 2017 |
Total current deferred revenue | $ 427,541 | $ 366,042 |
Total long-term deferred revenue | 453,106 | 423,929 |
Deferred maintenance revenue | ||
Total current deferred revenue | 171,980 | 162,958 |
Total long-term deferred revenue | 62,494 | 60,298 |
Unearned revenue | ||
Total current deferred revenue | 255,561 | 203,084 |
Total long-term deferred revenue | $ 390,612 | $ 363,631 |
Restructuring and Other Charg48
Restructuring and Other Charges, net (Accrual Activity Relating to Restructuring and Other Charges) (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Restructuring [Roll Forward] | ||
Balance at September 30, 2017 | $ 10,705 | |
Restructuring charges | 6,548 | $ 5,550 |
Restructuring Reserve, Accrual Adjustment | (298) | |
Cash payments | (7,145) | |
Balance at December 31, 2017 | 9,810 | |
Personnel | ||
Restructuring [Roll Forward] | ||
Balance at September 30, 2017 | 1,546 | |
Restructuring charges | 4,883 | |
Restructuring Reserve, Accrual Adjustment | 0 | |
Cash payments | (5,392) | |
Balance at December 31, 2017 | 1,037 | |
Facilities | ||
Restructuring [Roll Forward] | ||
Balance at September 30, 2017 | 9,159 | |
Restructuring charges | 1,665 | |
Restructuring Reserve, Accrual Adjustment | (298) | |
Cash payments | (1,753) | |
Balance at December 31, 2017 | $ 8,773 |
Restructuring and Other Charg49
Restructuring and Other Charges, net (By Segment) (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Restructuring Cost and Reserve [Line Items] | ||
Document Period End Date | Dec. 31, 2017 | |
Restructuring and other charges, net | $ 14,801 | $ 6,703 |
Restructuring charges | 6,548 | 5,550 |
Healthcare | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | 2,538 | 2,261 |
Restructuring charges | 2,538 | 2,261 |
Enterprise | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | 411 | 213 |
Restructuring charges | 411 | 213 |
Enterprise | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | 2,622 | 1,031 |
Restructuring charges | 2,622 | 1,031 |
Imaging | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | 1,232 | 712 |
Restructuring charges | 1,232 | 712 |
Corporate | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | 7,998 | 2,486 |
Restructuring charges | (255) | 1,333 |
Personnel | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | 3,651 | |
Restructuring charges | 4,883 | |
Personnel | Healthcare | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | 2,513 | 1,984 |
Personnel | Enterprise | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | 400 | 213 |
Personnel | Enterprise | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | 262 | 424 |
Personnel | Imaging | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | 1,223 | 361 |
Personnel | Corporate | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | 485 | 669 |
Facilities | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | 1,899 | |
Restructuring charges | 1,665 | |
Facilities | Healthcare | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | 25 | 277 |
Facilities | Enterprise | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | 11 | 0 |
Facilities | Enterprise | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | 2,360 | 607 |
Facilities | Imaging | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | 9 | 351 |
Facilities | Corporate | ||
Restructuring Cost and Reserve [Line Items] | ||
Restructuring and other charges, net | (740) | 664 |
Other Restructuring [Member] | ||
Restructuring Cost and Reserve [Line Items] | ||
Other Restructuring Costs | 8,253 | |
Other Restructuring [Member] | Healthcare | ||
Restructuring Cost and Reserve [Line Items] | ||
Other Restructuring Costs | 0 | 0 |
Other Restructuring [Member] | Enterprise | ||
Restructuring Cost and Reserve [Line Items] | ||
Other Restructuring Costs | 0 | 0 |
Other Restructuring [Member] | Enterprise | ||
Restructuring Cost and Reserve [Line Items] | ||
Other Restructuring Costs | 0 | 0 |
Other Restructuring [Member] | Imaging | ||
Restructuring Cost and Reserve [Line Items] | ||
Other Restructuring Costs | 0 | 0 |
Other Restructuring [Member] | Corporate | ||
Restructuring Cost and Reserve [Line Items] | ||
Other Restructuring Costs | 8,253 | 1,153 |
Chief Executive Officer [Member] | Other Restructuring [Member] | Corporate | ||
Restructuring Cost and Reserve [Line Items] | ||
Other Restructuring Costs | $ 2,300 | $ 1,153 |
Restructuring and Other Charg50
Restructuring and Other Charges, net (Additional Information) (Detail) $ in Thousands | 3 Months Ended | ||
Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | Sep. 30, 2017USD ($) | |
Restructuring Cost and Reserve [Line Items] | |||
Document Period End Date | Dec. 31, 2017 | ||
Restructuring Reserve | $ 9,810 | $ 10,705 | |
Document Fiscal Year Focus | 2,018 | ||
Restructuring charges | $ 6,548 | $ 5,550 | |
Number of personnel eliminated | 160 | 90 | |
Personnel | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and other charges, net | $ 3,651 | ||
Restructuring Reserve | $ 1,037 | 1,546 | |
Restructuring charges | 4,883 | ||
Facilities | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and other charges, net | 1,899 | ||
Restructuring Reserve | 8,773 | $ 9,159 | |
Restructuring charges | 1,665 | ||
Other Restructuring [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Other Restructuring Costs | 8,253 | ||
Malware Incident - Professional Service Charges [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Professional Fees | 6,000 | ||
Corporate | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring charges | (255) | 1,333 | |
Corporate | Personnel | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and other charges, net | 485 | 669 | |
Corporate | Facilities | |||
Restructuring Cost and Reserve [Line Items] | |||
Restructuring and other charges, net | (740) | 664 | |
Corporate | Other Restructuring [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Other Restructuring Costs | 8,253 | 1,153 | |
Corporate | Chief Executive Officer [Member] | Other Restructuring [Member] | |||
Restructuring Cost and Reserve [Line Items] | |||
Other Restructuring Costs | $ 2,300 | $ 1,153 |
Debt and Credit Facilities (Bor
Debt and Credit Facilities (Borrowing Obligations) (Detail) - USD ($) $ in Thousands | 3 Months Ended | ||||||
Dec. 31, 2017 | Sep. 30, 2017 | Sep. 30, 2016 | Dec. 22, 2016 | Jun. 21, 2016 | Oct. 22, 2012 | Aug. 14, 2012 | |
Debt Instrument [Line Items] | |||||||
Document Period End Date | Dec. 31, 2017 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months | $ 0 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Year Two | 0 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Year Three | 450,000 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Year Four | 0 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Year Five | 310,463 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five | 1,826,488 | ||||||
Total debt | 2,299,594 | $ 2,617,404 | |||||
Less: current portion | 0 | 376,121 | |||||
Total long-term debt | 2,299,594 | 2,241,283 | |||||
Debt Issuance Costs, Noncurrent, Net | (1,091) | (1,174) | |||||
Long-term Debt, Gross | 2,586,951 | ||||||
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | (287,357) | ||||||
5.625% Senior Notes due 2026 [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Senior Notes, net of unamortized premium | 494,453 | 494,298 | $ 500,000 | ||||
5.375% Senior Notes due August 15, 2020 | |||||||
Debt Instrument [Line Items] | |||||||
Senior Notes, net of unamortized premium | 448,748 | 448,630 | $ 350,000 | $ 700,000 | |||
Repayments of Debt | 600,000 | ||||||
6.0% Senior Notes due 2024 [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Senior Notes, net of unamortized premium | 297,988 | 297,910 | $ 300,000 | ||||
Convertible Debentures One Percent Due Twenty Thirty Five [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Senior Notes, net of unamortized premium | 534,885 | 528,690 | |||||
Convertible Debentures Two Point Seven Five Percent Due November One Twenty Thirty One [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Convertible Debentures, net of unamortized discount | 46,568 | 376,121 | |||||
Repayments of Debt | 331,200 | ||||||
1.25% Convertible Debentures due 2025 [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Convertible Debentures, net of unamortized discount | 255,703 | 253,054 | |||||
Convertible Debentures One Point Five Percent Due November One Twenty Thirty Five [Member] [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Convertible Debentures, net of unamortized discount | 222,340 | $ 219,875 | |||||
Term Loan Facility Due August Seventh Twenty Ninteen [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Repayments of Debt | $ 472,500 | ||||||
Senior Notes [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months | 0 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Year Two | 0 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Year Three | 450,000 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Year Four | 0 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Year Five | 0 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five | 800,000 | ||||||
Total debt | 1,240,098 | ||||||
Long-term Debt, Gross | 1,250,000 | ||||||
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | (9,902) | ||||||
Convertible Debt [Member] | |||||||
Debt Instrument [Line Items] | |||||||
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months | 0 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Year Two | 0 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Year Three | 0 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Year Four | 0 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Year Five | 310,463 | ||||||
Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five | 1,026,488 | ||||||
Total debt | 1,059,496 | ||||||
Long-term Debt, Gross | 1,336,951 | ||||||
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | $ (277,455) |
Debt and Credit Facilities Borr
Debt and Credit Facilities Borrowing Obligations Detail (Details) - USD ($) $ in Millions | Dec. 31, 2017 | Sep. 30, 2017 |
Borrowing Obligations Detail [Abstract] | ||
Long-term Debt, Fair Value | $ 2,627.2 | $ 2,930.9 |
Debt Instrument, Face Amount | $ 2,587 | $ 2,918.1 |
Debt and Credit Facilities 5.37
Debt and Credit Facilities 5.375% Senior Notes due 2020 (Details) - USD ($) $ in Thousands | 3 Months Ended | ||||
Dec. 31, 2017 | Sep. 30, 2017 | Jan. 09, 2017 | Oct. 22, 2012 | Aug. 14, 2012 | |
Debt Instrument [Line Items] | |||||
Debt Instrument, Face Amount | $ 2,587,000 | $ 2,918,100 | |||
Document Period End Date | Dec. 31, 2017 | ||||
5.375% Senior Notes due August 15, 2020 | |||||
Debt Instrument [Line Items] | |||||
Debt Instrument, Face Amount | $ 450,000 | ||||
Senior Notes, Noncurrent | $ 448,748 | $ 448,630 | $ 350,000 | $ 700,000 | |
Debt Instrument, Interest Rate, Stated Percentage | 5.375% | 5.375% | 5.375% | ||
Unamortized Debt Issuance Expense | $ 2,100 | $ 7,300 | |||
Repayments of Debt | 600,000 | ||||
Loss on extinguishment of debt | $ 18,600 |
Debt and Credit Facilities 6.0%
Debt and Credit Facilities 6.0% Senior Notes due 2024 (Details) - USD ($) $ in Thousands | 3 Months Ended | |||||
Dec. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Sep. 30, 2017 | Dec. 22, 2016 | Jun. 21, 2016 | |
Debt Instrument [Line Items] | ||||||
Proceeds from Issuance of Long-term Debt | $ 0 | $ 495,000 | ||||
5.625% Senior Notes due 2026 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior Notes, Noncurrent | $ 494,453 | $ 494,298 | $ 500,000 | |||
Debt Instrument, Interest Rate, Stated Percentage | 5.625% | 5.625% | ||||
Unamortized Debt Issuance Expense | $ 5,500 | |||||
6.0% Senior Notes due 2024 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Senior Notes, Noncurrent | $ 297,988 | $ 297,910 | $ 300,000 | |||
Debt Instrument, Interest Rate, Stated Percentage | 6.00% | 6.00% | 6.00% | |||
Proceeds from Issuance of Long-term Debt | $ 297,500 | |||||
Unamortized Debt Issuance Expense | $ 2,000 | |||||
Asset Sale [Member] | 5.625% Senior Notes due 2026 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Aggregate Principal Amount of Senior Notes, Redemption Price, Percentage | 100.00% | |||||
Change of Control [Member] | 5.625% Senior Notes due 2026 [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Aggregate Principal Amount of Senior Notes, Redemption Price, Percentage | 101.00% |
Debt and Credit Facilities 1.0%
Debt and Credit Facilities 1.0% Convertible Debentures due 2035 (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||
Dec. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Dec. 31, 2015 | Jun. 30, 2015 | Sep. 30, 2017 | Dec. 07, 2015 | Jun. 01, 2015 | Oct. 24, 2011 | |
Debt Instrument [Line Items] | |||||||||
Debt Instrument, Face Amount | $ 2,587,000 | $ 2,918,100 | |||||||
Proceeds from Issuance of Long-term Debt | 0 | $ 495,000 | |||||||
Debt Issuance Costs, Noncurrent, Net | $ 1,091 | $ 1,174 | |||||||
Convertible Debentures One Percent Due Twenty Thirty Five [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt Instrument, Face Amount | $ 676,500 | ||||||||
Debt Instrument, Convertible, Carrying Amount of Equity Component | $ 181,100 | ||||||||
Debt Instrument, Convertible, Conversion Price | $ 27.22 | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 1.00% | 1.00% | 1.00% | ||||||
Convertible Debt, Noncurrent | $ 495,400 | ||||||||
Convertible Debentures Two Point Seven Five Percent Due November One Twenty Thirty One [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt Instrument, Face Amount | $ 46,600 | $ 377,700 | $ 690,000 | ||||||
Debt Instrument, Convertible, Carrying Amount of Equity Component | $ 156,400 | ||||||||
Debt Instrument, Convertible, Conversion Price | $ 32.30 | ||||||||
Repayments of Convertible Debt | $ 38,300 | $ 256,200 | $ 17,800 | ||||||
Debt Instrument, Interest Rate, Stated Percentage | 2.75% | 2.75% | 2.75% | ||||||
Repayments of Debt | $ 331,200 | ||||||||
Convertible Debt, Noncurrent | $ 533,600 | ||||||||
Term Loan Facility Due August Seventh Twenty Ninteen [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Repayments of Debt | $ 472,500 | ||||||||
Gain (Loss) on Extinguishment of Debt | $ 4,900 | ||||||||
Convertible Debentures One Point Five Percent Due November One Twenty Thirty Five [Member] [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Debt Instrument, Face Amount | $ 263,900 | ||||||||
Debt Instrument, Convertible, Carrying Amount of Equity Component | $ 55,300 | ||||||||
Debt Instrument, Convertible, Conversion Price | $ 23.26 | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 1.50% | 1.50% | 1.50% | ||||||
Convertible Debt, Noncurrent | $ 208,600 |
Debt and Credit Facilities 2.75
Debt and Credit Facilities 2.75% Convertible Debentures due 2031 (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | 12 Months Ended | ||||
Dec. 31, 2017 | Sep. 30, 2016 | Jun. 30, 2015 | Sep. 30, 2017 | Dec. 07, 2015 | Oct. 24, 2011 | |
Debt Instrument [Line Items] | ||||||
Debt Instrument, Face Amount | $ 2,587,000 | $ 2,918,100 | ||||
Debt Issuance Costs, Noncurrent, Net | 1,091 | 1,174 | ||||
Convertible Debentures Two Point Seven Five Percent Due November One Twenty Thirty One [Member] | ||||||
Debt Instrument [Line Items] | ||||||
Repayments of Convertible Debt | $ 38,300 | $ 256,200 | 17,800 | |||
Debt Instrument, Face Amount | 46,600 | $ 377,700 | $ 690,000 | |||
Repayments of Debt | 331,200 | |||||
Debt Instrument, Convertible, Conversion Price | $ 32.30 | |||||
Debt Instrument, Unamortized Discount | $ 0 | $ 1,500 | ||||
Convertible Debt, Noncurrent | $ 533,600 | |||||
Debt Instrument, Convertible, Carrying Amount of Equity Component | $ 156,400 | |||||
Debt Instrument, Interest Rate, Stated Percentage | 2.75% | 2.75% | 2.75% |
Debt and Credit Facilities 1.5%
Debt and Credit Facilities 1.5% Convertible Debentures due 2035 (Details) - USD ($) $ / shares in Units, $ in Thousands | Dec. 31, 2017 | Sep. 30, 2017 | Jun. 01, 2015 |
Debt Instrument [Line Items] | |||
Debt Instrument, Face Amount | $ 2,587,000 | $ 2,918,100 | |
Debt Issuance Costs, Noncurrent, Net | $ 1,091 | $ 1,174 | |
Convertible Debentures One Point Five Percent Due November One Twenty Thirty Five [Member] [Member] | |||
Debt Instrument [Line Items] | |||
Debt Instrument, Face Amount | $ 263,900 | ||
Debt Instrument, Interest Rate, Stated Percentage | 1.50% | 1.50% | 1.50% |
Debt Instrument, Convertible, Conversion Price | $ 23.26 | ||
Debt issuance Percentage of Principal Amount | 97.09% | ||
Debt Instrument, Unamortized Discount (Premium), Net | $ 7,700 | ||
Debt Instrument, Unamortized Discount | $ 40,100 | ||
Convertible Debt, Noncurrent | 208,600 | ||
Debt Instrument, Convertible, Carrying Amount of Equity Component | $ 55,300 |
Debt and Credit Facilities Cred
Debt and Credit Facilities Credit Facility (Details) - USD ($) $ in Thousands | 3 Months Ended | ||||
Sep. 30, 2016 | Dec. 31, 2015 | Dec. 31, 2017 | Sep. 30, 2017 | Apr. 15, 2016 | |
Line of Credit Facility [Line Items] | |||||
Debt Issuance Costs, Noncurrent, Net | $ 1,091 | $ 1,174 | |||
Revolving Credit Facility [Member] | |||||
Line of Credit Facility [Line Items] | |||||
Line of Credit Facility, Maximum Borrowing Capacity | 238,000 | $ 242,500 | |||
Letters of Credit Outstanding, Amount | $ 4,500 | ||||
Term Loan Facility Due August Seventh Twenty Ninteen [Member] | |||||
Line of Credit Facility [Line Items] | |||||
Repayments of Debt | $ 472,500 | ||||
Loss on extinguishment of debt | $ (4,900) |
Debt and Credit Facilities Appl
Debt and Credit Facilities Applicable Borrowing Rates and Additional Detail (Details) - USD ($) $ in Millions | 3 Months Ended | |||||||
Dec. 31, 2017 | Sep. 30, 2017 | Dec. 22, 2016 | Jun. 21, 2016 | Dec. 07, 2015 | Jun. 01, 2015 | Aug. 14, 2012 | Oct. 24, 2011 | |
Revolving Credit Facility [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Unamortized Discount | $ 0 | $ 0 | ||||||
5.625% Senior Notes due 2026 [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 5.625% | 5.625% | ||||||
Debt Instrument, Interest Rate, Effective Percentage | 5.625% | |||||||
nuan_DebtInstrumentMaturityYear | 2,026 | |||||||
Unamortized Debt Issuance Expense | $ 5.5 | |||||||
6.0% Senior Notes due 2024 [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 6.00% | 6.00% | 6.00% | |||||
Debt Instrument, Interest Rate, Effective Percentage | 6.00% | 6.00% | ||||||
nuan_DebtInstrumentMaturityYear | 2,024 | |||||||
Unamortized Debt Issuance Expense | $ 2 | |||||||
Debt Instrument, Unamortized Premium | $ 0 | $ 0 | ||||||
5.375% Senior Notes due August 15, 2020 | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 5.375% | 5.375% | 5.375% | |||||
Debt Instrument, Interest Rate, Effective Percentage | 5.28% | 5.28% | ||||||
nuan_DebtInstrumentMaturityYear | 2,020 | |||||||
Unamortized Debt Issuance Expense | $ 2.1 | $ 7.3 | ||||||
Debt Instrument, Unamortized Premium | $ (0.9) | $ (1) | ||||||
Convertible Debentures Two Point Seven Five Percent Due November One Twenty Thirty One [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 2.75% | 2.75% | 2.75% | |||||
Debt Instrument, Interest Rate, Effective Percentage | 7.432% | 7.43% | ||||||
nuan_DebtInstrumentMaturityYear | 2,031 | |||||||
Unamortized Debt Issuance Expense | $ 0 | $ 1.1 | ||||||
Debt Instrument, Unamortized Discount | $ 0 | $ 1.5 | ||||||
Convertible Debentures One Point Five Percent Due November One Twenty Thirty Five [Member] [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 1.50% | 1.50% | 1.50% | |||||
Debt Instrument, Interest Rate, Effective Percentage | 5.394% | 5.39% | ||||||
nuan_DebtInstrumentMaturityYear | 2,035 | |||||||
Unamortized Debt Issuance Expense | $ 1.4 | $ 1.9 | ||||||
Debt Instrument, Unamortized Discount | $ 40.1 | |||||||
Convertible Debentures One Percent Due Twenty Thirty Five [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 1.00% | 1.00% | 1.00% | |||||
Debt Instrument, Interest Rate, Effective Percentage | 5.622% | 5.62% | ||||||
nuan_DebtInstrumentMaturityYear | 2,035 | |||||||
Unamortized Debt Issuance Expense | $ 6.6 | $ 8.2 | ||||||
Debt Instrument, Unamortized Discount | $ 135 | $ 140.9 | ||||||
Convertible Debentures 1.25% Due 2025 [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 1.25% | |||||||
Debt Instrument, Interest Rate, Effective Percentage | 5.578% | |||||||
nuan_DebtInstrumentMaturityYear | 2,025 | |||||||
Unamortized Debt Issuance Expense | $ 4.1 | |||||||
Debt Instrument, Unamortized Discount | $ 90.2 | |||||||
Minimum [Member] | Revolving Credit Facility Due April Fifteenth Twenty Twenty One [Member] | Base Rate [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Basis Spread on Variable Rate | 0.50% | |||||||
Minimum [Member] | Revolving Credit Facility Due April Fifteenth Twenty Twenty One [Member] | London Interbank Offered Rate [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Basis Spread on Variable Rate | 1.50% | |||||||
Maximum | Revolving Credit Facility Due April Fifteenth Twenty Twenty One [Member] | Base Rate [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Basis Spread on Variable Rate | 0.75% | |||||||
Maximum | Revolving Credit Facility Due April Fifteenth Twenty Twenty One [Member] | London Interbank Offered Rate [Member] | ||||||||
Debt Instrument [Line Items] | ||||||||
Debt Instrument, Basis Spread on Variable Rate | 1.75% |
Debt and Credit Facilities 5.62
Debt and Credit Facilities 5.625% Senior Notes due December 2026 (Details) - USD ($) $ in Thousands | 3 Months Ended | ||
Dec. 31, 2017 | Sep. 30, 2017 | Dec. 22, 2016 | |
Debt Instrument [Line Items] | |||
Document Period End Date | Dec. 31, 2017 | ||
5.625% Senior Notes due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Senior Notes, Noncurrent | $ 494,453 | $ 494,298 | $ 500,000 |
Debt Instrument, Interest Rate, Stated Percentage | 5.625% | 5.625% | |
Proceeds from Issuance of Senior Long-term Debt | $ 495,000 | ||
Change of Control [Member] | 5.625% Senior Notes due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Aggregate Principal Amount of Senior Notes, Redemption Price, Percentage | 101.00% | ||
Before December 15, 2021 [Member] | 5.625% Senior Notes due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Aggregate Principal Amount of Senior Notes, Redemption Price, Percentage | 100.00% | ||
Aggregate Principal Amount of Senior Notes, Redemption of Principal Amount, Percentage | 35.00% | ||
Before December 15, 2021 [Member] | 5.625% Senior Notes due 2026 [Member] | Minimum [Member] | |||
Debt Instrument [Line Items] | |||
Aggregate Principal Amount of Senior Notes, Redemption of Principal Amount, Percentage | 50.00% | ||
Asset Sale [Member] | 5.625% Senior Notes due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Aggregate Principal Amount of Senior Notes, Redemption Price, Percentage | 100.00% | ||
At any time and from time to time before December 15, 2021 [Member] | 5.625% Senior Notes due 2026 [Member] | |||
Debt Instrument [Line Items] | |||
Aggregate Principal Amount of Senior Notes, Redemption Price, Percentage | 105.625% |
Debt and Credit Facilities 1.25
Debt and Credit Facilities 1.25% Convertible Debentures due 2025 (Details) - USD ($) $ / shares in Units, $ in Thousands, shares in Millions | 3 Months Ended | 12 Months Ended | 50 Months Ended | ||||||
Dec. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2015 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 13, 2017 | Dec. 07, 2015 | Oct. 24, 2011 | |
Debt Instrument [Line Items] | |||||||||
Document Period End Date | Dec. 31, 2017 | ||||||||
Debt Instrument, Face Amount | $ 2,587,000 | $ 2,918,100 | |||||||
Proceeds from Issuance of Long-term Debt | 0 | $ 495,000 | |||||||
Stock Repurchased and Retired During Period, Shares | 5.8 | 46.5 | |||||||
Stock Repurchased During Period, Value | $ 99,100 | $ 806,600 | |||||||
Convertible Debentures 1.25% Due 2025 [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Convertible Debt, Noncurrent | $ 252,100 | ||||||||
Debt Instrument, Face Amount | 350,000 | ||||||||
Proceeds from Issuance of Long-term Debt | 343,600 | ||||||||
Debt Instrument, Convertible, Carrying Amount of Equity Component | $ 97,900 | ||||||||
Debt Instrument, Convertible, Conversion Price | $ 22.22 | ||||||||
Convertible Debentures Two Point Seven Five Percent Due November One Twenty Thirty One [Member] | |||||||||
Debt Instrument [Line Items] | |||||||||
Convertible Debt, Noncurrent | $ 533,600 | ||||||||
Debt Instrument, Face Amount | $ 46,600 | $ 377,700 | 690,000 | ||||||
Repayments of Convertible Debt | $ 38,300 | $ 256,200 | $ 17,800 | ||||||
Debt Instrument, Convertible, Carrying Amount of Equity Component | $ 156,400 | ||||||||
Debt Instrument, Convertible, Conversion Price | $ 32.30 |
Stockholders' Equity Stockhol62
Stockholders' Equity Stockholders' Equity (Details) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 12 Months Ended | 50 Months Ended | |||
Dec. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2017 | Jun. 30, 2017 | Apr. 29, 2015 | Apr. 29, 2013 | |
Stockholders Equity Note [Line Items] | ||||||
Stock Repurchase Program, Number of Shares Authorized to be Repurchased, Value | $ 500 | $ 500 | ||||
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased | $ 193.4 | |||||
Stock Repurchased and Retired During Period, Shares | 5.8 | 46.5 | ||||
Stock Repurchased During Period, Value | $ 99.1 | $ 806.6 | ||||
Other Acquisitions [Member] | ||||||
Stockholders Equity Note [Line Items] | ||||||
Payments to Acquire Businesses, Gross | $ 8.7 | $ 24.2 |
Net Income (Loss) Per Share (Ad
Net Income (Loss) Per Share (Additional Information) (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Net income (loss) | $ 53,228 | $ (23,929) |
Weighted Average Number of Shares Outstanding, Basic | 291,367 | 288,953 |
Dilutive Securities, Effect on Basic Earnings Per Share | 4,628 | 0 |
Weighted Average Number of Shares Outstanding, Diluted | 295,995 | 288,953 |
Earnings Per Share, Basic | $ 0.18 | $ (0.08) |
Weighted Average Number of Shares, Contingently Issuable | 2,200 | 2,800 |
Anti-dilutive common equivalent shares excluded from computation of diluted net income (loss) per share | 100 | 7,100 |
Stock-Based Compensation (Inclu
Stock-Based Compensation (Included in Consolidated Statements of Operations) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Document Period End Date | Dec. 31, 2017 | |
Stock based compensation | $ 37,986 | $ 39,130 |
Cost of professional services and hosting | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock based compensation | 7,407 | 8,410 |
Cost of product and licensing | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock based compensation | 266 | 92 |
Cost of maintenance and support | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock based compensation | 1,204 | 977 |
Research and development | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock based compensation | 9,696 | 8,490 |
Sales and marketing | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock based compensation | 10,676 | 11,969 |
General and administrative | ||
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ||
Stock based compensation | $ 8,737 | $ 9,192 |
Stock-Based Compensation (Summa
Stock-Based Compensation (Summary of Activity Relating to Restricted Units) (Detail) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | |||
Dec. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2017 | Jun. 30, 2016 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 21,948 | 23,807 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | $ 0 | $ 0.7 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term | 2 years 9 months | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | $ 16.41 | $ 16.29 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | $ 0.1 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | 21,939 | 1,050,038 | ||
Restricted Units, Outstanding [Roll Forward] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term | 2 years 9 months | 1 year | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | $ 0.1 | $ 0.2 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | $ 16.40 | $ 15.39 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | 1,859 | |||
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | $ 3.41 | |||
Closing market value of common stock | 16.35 | |||
Restricted Stock Units | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Purchase price for restricted units, vested | $ 0.001 | |||
Number of Shares Underlying Restricted Units — Contingent Awards | ||||
Restricted Units, Outstanding [Roll Forward] | ||||
Outstanding at September 30, 2017 | 5,043,931 | |||
Granted | 688,999 | |||
Earned/released | (1,687,862) | |||
Forfeited | (893,287) | |||
Outstanding at December 31, 2017 | 3,151,781 | |||
Weighted average remaining recognition period of outstanding restricted units | 1 year 2 months | |||
Unrecognized stock-based compensation expense of outstanding restricted units | $ 45 | |||
Aggregate intrinsic value of outstanding restricted units(a) | $ 51.5 | |||
Number of Shares Underlying Restricted Units — Time-Based Awards | ||||
Restricted Units, Outstanding [Roll Forward] | ||||
Outstanding at September 30, 2017 | 6,477,164 | |||
Granted | 4,263,946 | |||
Earned/released | (3,614,185) | |||
Forfeited | (168,642) | |||
Outstanding at December 31, 2017 | 6,958,283 | |||
Weighted average remaining recognition period of outstanding restricted units | 1 year 9 months | |||
Unrecognized stock-based compensation expense of outstanding restricted units | $ 79.8 | |||
Aggregate intrinsic value of outstanding restricted units(a) | $ 113.9 |
Stock-Based Compensation (Sum66
Stock-Based Compensation (Summary of Weighted-Average Grant-Date Fair Value and Intrinsic Value of Restricted Units Vested) (Detail) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Document Period End Date | Dec. 31, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | $ 0 | $ 0.7 |
Restricted Stock Units | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Weighted-average grant-date fair value per share | $ 14.92 | $ 15.90 |
Total intrinsic value of shares vested (in millions) | $ 84.7 | $ 88.3 |
Income Taxes Components of Inco
Income Taxes Components of Income (Loss) Before Income Taxes (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Components of Income (Loss) before Income Taxes [Abstract] | ||
Domestic | $ (40,031) | $ (47,583) |
Foreign | 14,738 | 34,007 |
Loss before income taxes | $ (25,293) | $ (13,576) |
Income Taxes (Components of Ben
Income Taxes (Components of Benefit from Income Taxes) (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Income Tax Disclosure [Abstract] | ||
Gross Income Tax Benefit from New Tax Legislation | $ 96,000 | |
Domestic | (80,866) | $ 4,159 |
Foreign | 2,345 | 6,194 |
(Benefit) provision for income taxes | $ (78,521) | $ 10,353 |
Effective tax rate | 310.40% | (76.30%) |
One-Time Repatriation Tax | $ 14,000 |
Commitments and Contingencies (
Commitments and Contingencies (Details) | 3 Months Ended |
Dec. 31, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Indemnification term for former officers and directors | 6 years |
Segment and Geographic Inform70
Segment and Geographic Information and Significant Customers (Segment Results Along with Reconciliation of Segment Profit to Income Before Income Taxes) (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Segment Reporting Information [Line Items] | ||
Document Period End Date | Dec. 31, 2017 | |
Segment Revenues | $ 508,825 | $ 496,019 |
Revenues | 501,645 | 487,658 |
Segment profit | 157,420 | 161,612 |
Corporate expenses and other, net | (44,665) | (30,959) |
Acquisition-related revenues | (7,180) | (8,361) |
Stock-based compensation | (37,986) | (39,130) |
Amortization of intangible assets | (38,420) | (43,401) |
Acquisition-related costs, net | (5,561) | (9,026) |
Restructuring and other charges, net | (14,801) | (6,703) |
Other expenses, net | (34,100) | (37,608) |
Loss before income taxes | (25,293) | (13,576) |
Healthcare | ||
Segment Reporting Information [Line Items] | ||
Segment Revenues | 245,535 | 239,208 |
Segment profit | 77,419 | 78,567 |
Restructuring and other charges, net | (2,538) | (2,261) |
Mobile And Consumer Segment | ||
Segment Reporting Information [Line Items] | ||
Segment Revenues | 89,829 | 91,784 |
Segment profit | 25,423 | 33,471 |
Restructuring and other charges, net | (411) | (213) |
Enterprise | ||
Segment Reporting Information [Line Items] | ||
Segment Revenues | 117,831 | 112,938 |
Segment profit | 38,935 | 31,958 |
Restructuring and other charges, net | (2,622) | (1,031) |
Imaging | ||
Segment Reporting Information [Line Items] | ||
Segment Revenues | 55,630 | 52,089 |
Segment profit | 15,643 | 17,616 |
Restructuring and other charges, net | (1,232) | (712) |
Less: acquisition-related revenues adjustments | ||
Segment Reporting Information [Line Items] | ||
Revenues | $ 7,180 | $ 8,361 |
Segment and Geographic Inform71
Segment and Geographic Information and Significant Customers (Classification of Revenue by Major Geographic Areas) (Detail) - USD ($) $ in Thousands | 3 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Document Period End Date | Dec. 31, 2017 | |
Segment Revenues | $ 508,825 | $ 496,019 |
Total revenues | 501,645 | 487,658 |
UNITED STATES | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Segment Revenues | 364,286 | 349,170 |
International [Member] | ||
Revenues from External Customers and Long-Lived Assets [Line Items] | ||
Segment Revenues | $ 137,359 | $ 138,488 |